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The chief purpose of this dissertation is to document 
the design and performance of an automatically-regulated 
artificial ventricle used for short-term animal experiments. 
The overall objective of the work was to develop an arti­
ficial ventricle system of low biological reactance 
(physically, chemically, and functionally) for studies of 
regulation of the pulmonary and systemic blood vascular 
systems in experimental animals. A major aim was a study 
of various combinations of animal-machine feedback control 
mechanisms in order to find the most appropriate physiologic 
parameter or combination of parameters which must be 
monitored and utilized to regulate the fluid output of the 
artificial ventricles in response to a subject's changing 
circulatory requirements. This objective was, in part, 
accomplished by use of the capabilities of an artificial 
ventricle system herein described. 
To adequately provide, by electromechanical means, the 
exact functional duplication of and substitution for any 
living organ can be a prodigious task. However, once the 
principal overall function of the organ is defined and 
understood, the design of a device (or, more likely, a 
system) to reproduce just that function can be undertaken. 
The heart is an organ which lends itself very well to 
an easy understanding and exact definition of its principal 
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function, that of "being basically a pump. Its primary 
purpose is to provide a pulsatile blood flow to all the 
cells in the body for tissue oxygenation, nourishment, and 
removal of wastes. 
This apparently simple job asked of the heart is not 
at first what it seems to be. The heart is a strong 
muscular organ about the size of a large fist and weighs 
approximately I/3OO of the body weight (123). To keep 
all the blood in the body (about eight percent of the body 
weight) in continual circulation through the miles of blood 
vessels, the normal heart is called upon to perform the 
following minimal tasks. 
1. It must contract about 72 times each minute 
or more than 100,000 times each day. 
2. It must pump about five liters of blood each 
minute cr about 7200 liters (1900 gallons) 
each day. 
3. Its power requirement is about 3.73 watts (51). 
This is an energy requirement of 88.5 watt-
hours per day. If this energy were available 
directly from an electric utility company., the 
cost per year, at four cents per kilowatt-hour, 
would be #1.301 
The normal heart has a resting duty cycle of about 67 
percent. But it can double both its rate and fluid output 
during periods of strenuous physical exercise or emotional 
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strain. The faster the heart beats the harder it works 
and the less time it has to rest. 
Considering the work the heart is called upon to deliver, 
it is not surprising that nearly a fourth of the U.S. adult 
population lives under a threat of heart disease and that 
there are more than 500,000 deaths each year from coronary 
artery disease (63), This means that heart disease is the 
top killer in the ÏÏ.S. today, and strokes rank third, just 
behind cancer. But heart disease and strokes both develop 
from arterial diseases and together they account for 75 
percent of all ÏÏ.S. deaths (116). The conclusion to be 
drawn, then, is that cardiovascular disease is probably the 
most pressing problem of modern medicine. 
Considerable money and research, effort has been expended 
in combating this many-sided heart disease problem. The 
fight has been greatly aided by many new drugs, surgical 
and recovery procedures, ideas, materials, and machines. 
The use of heart-lung machines outside the body for tem­
porary maintenance of circulation during heart surgery is 
well known. 
However, there are many patients with irreversibly 
damaged hearts who cannot benefit from cardiac surgery at 
the present stage of technical development. Total replace­
ment of the heart is perhaps the only way the lives of 
these persons could be saved. The possibility of being able 
to transplant a living heart into the human body may offer 
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a solution. But this creates a dilemma — not only are 
there immunologic problems but also there exists the 
difficulty of procuring either a human or an animal heart. 
According to Nose (89) there are approximately only 500 
potential donors of the heterologous heart if the chim­
panzee must be relied upon. 
Probably as an extension of the heart-lung machine 
came the idea of the replacement of a patient's failing 
heart with a mechanical one to take over completely and 
permanently the function of the natural heart. Recent 
engineering progress has made the permanent replacement 
of the human heart with an intrathoracic artificial heart 
a definite possibility for the future, 
Regardless of how the time sequence of thoughts for 
heart replacement went, the first experimenter to attempt 
the implantation of a mechanical heart inside the body 
was apparently Y.P. Demikhov, a Soviet investigator (63).  
In 1937 he performed three experiments in which a pumping 
device was implanted in animals. The pump was externally 
driven by a rotating shaft inserted into the animal through 
a tube in the chest wall. Probably the first artificial 
heart experiment in the U.S, was performed i^  December, 
1957, at the Cleveland Clinic, An air-driven artificial 
heart was implanted inside the chest of a dog, and the 
animal survived for 90 minutes (63). There are now in 
excess of 30 groups engaging in research on and development 
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of artificial hearts and closely allied problems. The 
group "With which the author has been associated is one of 
the 30. The Iowa State University Artificial Heart Program 
has devoted its effort to the development of both heart 
models and control systems. The research was supported 
by Iowa State University, the Iowa Heart Association, the 
American Heart Association, and the Iowa State University 
Affiliate Program in Solid State Electronics. 
To gain a better understanding of the problems involved 
in developing an artificial ventricle and its power and 
control systems, the anatomy and physiology of the normal 
intact heart will be described. The description will also 
include a discussion of the normal heart's accompanying 
loads (pulmonary and systemic circulatory systems) and 
control mechanisms (nervous, humoral, and intrinsic). 
Following this,.various important aspects of mechanical 
artificial hearts in general (ideal specifications, types 
of pumps already developed, materials and valves, blood 
trauma, power, and control) will be discussed. This section 
will conclude with a description of various cardiac devices 
which are designed for short-term assistance of a mal­
functioning but recuperating natural heart. Then the 
artificial ventricles developed in this study and their 
power and control systems will be documented and the 
experimental results, both 3^  vivo and 3^  vitro, will be 
discussed. 
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THE CARDIOVASCULAR SYSTEM 
General Outline 
of the Cardiovascular System 
Figure 1 shows the general plan of the human circula­
tory system. In the figure, all the arteries and veins are 
shown as single large distensible chambers. The actual 
system consists of a network of blood vessels and the 
heart which pumps blood through them. The heart is composed 
of four chambers: right and left atria and right and left 
ventricles. The atria, although acting as weak pumps to 
transfer blood from the systemic and pulmonary veins to the 
ventricles, primarily serve as entryways for the two 
ventricles. The ventricles provide the main propelling 
force to move the blood. 
There are two major subdivisions of the circulatory 
system, the systemic circulation and the pulmonary circu­
lation. Prom the right ventricle blood enters the pulmo­
nary artery, passes through the lungs, and returns via the 
pulmonary veins to the left atrium, thus completing the 
pulmonary circulation. Prom the left atrium blood flows 
into the left ventricle, then through the aorta and its 
branches to all parts of the body, and, returning to the 
heart, enters the right atrium, thus completing the systemic 
circulation. 
The aorta and the pulmonary artery undergo repeated 
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division with, successive "branches (arteries) gradually 
diminishing in size. The smallest arterial "branches are 
called arterioles. The arterioles divide to form the 
network of capillaries which are the smallest of all the 
blood vessels. Then the post-capillary vessels undergo 
a progressive increase in size. Capillaries join to form . 
small veins or venules, which in turn combine to give rise 
to the larger veins. These become bigger as they receive 
additional tributaries, until they finally form the large 
veins which enter the heart. Blood from the lungs is 
returned to the heart in the pulmonary veins, and from 
the rest of the body in the superior and inferior vena 
cavae. 
The cardiac cycle, which averages 833 milliseconds 
is composed of a period of muscle relaxation called 
diastole (555 milliseconds) followed by a period of muscle 
contraction called systole (278 milliseconds).^  The 
ventricles are filled with blood during diastole and expel 
the blood during systole. The atria and ventricles do not 
contract simultaneously. The atria contract first, filling 
the relaxed ventricles and then relax while the ventricles 
contract. 
U^nless as noted to the contrary, all cardiovascular 
data will apply to the human. 
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The heart, to ensure unidirectional blood flow, has 
four valves: mitral, tricuspid, aortic, and pulmonary. 
Figure 2 shows in block diagram form the four heart 
chambers, the body and lungs, and the four heart valves 
(each represented by an ideal electrical diode). The mitral 
(or bicuspid) and tricuspid valves, which are the left 
and right atrioventricular (AV) valves, respectively, 
prevent backflow of blood from the ventricles to the atria 
during systole. The aortic and pulmonary valves, which are 
the left and right semilunar valves, respectively, prevent 
backflow from the aorta and pulmonary artery into the 
ventricles during diastole. The AY valves are open during 
diastole and the semilunar valves are open during systole. 
It is supposed that these valves open and close passively 
with their action depending only upon the pressure gradient 
across them and not on any intrinsic muscles connected to 
the valves themselves (123).  
When the ventricles contract, they do not empty com­
pletely. The amount of blood remaining in each ventricle 
is called the end-systolic volume and it averages 80 
milliliters. During diastole each ventricle fills to an 
average volume of 150 milliliters — this is called the 
end-diastolic volume. The amount of blood ejected with 
each heart beat is the difference between the end-diastolic 
and end-systolic volumes and is called the stroke volume. 
It averages 70 milliliters for each ventricle. 
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The amount of blood pumped by the heart each minute is 
called the cardiac output and in a resting, normal 70 
kilogram adult averages almost 5.0 liters per minute. The 
cardiac output is obviously equal to the stroke volume in 
liters times the heart rate in beats per minute. This very 
important relationship when carried over to the design of 
an artificial pumping device shows that two main methods 
are available to alter the fluid output of the pimp. 
Blood pressure is the force ezerted by the blood against 
any unit area of the vessel wall. It can be measured in 
dynes per square centimeter or, more customarily, in 
millimeters of mercury (mm. Eg). The conversion between 
the two is; 1 mm. Eg = 1,353 dynes per square centimeter. 
When the left ventricle empties, the normal peak 
aortic pressure (or systolic pressure) is 120 mm. Eg. This 
ejection of blood into the arterial system causes the 
arterial walls to stretch and raises the pressure in the 
arterial system. After the aortic valve is closed, the 
aortic pressure falls slowly throughout diastole. This 
pressure, in the normal human being, usually falls to 
approximately 80 mm. Eg (diastolic pressure) by the time 
the ventricle contracts again. The difference between the 
aortic systolic and diastolic pressures is called the 
pulse pressure and it averages 40 mm. Eg. The pressures in 
the pulmonary artery are similar in shape to those in the 
aorta only with lower systolic (approximately 22 mm. Eg), 
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diastolic (approximately eight mm. Eg), and pulse (approx­
imately 14 mm. Eg) pressures. 
The actual blood pressure at any point in the circu­
latory system is determined by several factors: 1) the 
amount of blood in the circulatory system; 2) the pumping 
activity of the heart; 3) a vessel's resistance to blood 
flow; and 4) blood density and viscosity. 
Another term which will be of importance later is the 
mean circulatory pressure (MOP). This is the pressure 
that would be measured in the circulation if one could 
instantaneously stop all blood flow and could bring all the 
pressures in the circulation immediately to equilibrium. 
This value has been found to be almost exactly seven mm. Eg 
(51). The importance of the mean circulatory pressure is 
that it is one of the major factors that determines the 
rate at which blood flows from the vascular tree into the 
right atrium of the heart, and, therefore, helps to control 
the cardiac output itself. 
The heart derives its rich blood supply from the 
right and left coronary arteries which arise from the base 
of the aorta just above the aortic valve. Blood returning 
from the tissues of the heart itself flows through the 
coronary sinus into the right atrium or returns by a number 
of smaller vessels to the atria and ventricles. 
The average weight of the normal adult heart is about 
312 grams in the male and 255 grams in the female. Its 
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approsimate dimensions are; length., 12,7 centimeters; 
width, 8.9 centimeters; and depth, 6,35 centimeters. The 
adult heart is about 1/300 of the body weight (123). 
The main mass of the heart is formed by its muscular 
tissue or myocardium, lined internally by endocardium and 
externally by the pericardial tissue layer known as 
epicardium. In addition, there are blood and lymphatic 
vessels, nerves, varying amounts of fat and areolar tissue, 
and specialized conducting tissues. 
The heart is composed of three types of cardiac muscle 
atrial muscle, ventricular muscle, and Purkinje muscle 
fibers. The atrial and ventricular muscles act in a 
manner similar to skeletal muscle, while the Purkinje 
fibers provide a rapid transmission path for the conduction 
of impulses. 
The heart-beat commences in the sinoatrial node lo­
cated on the right atrium. This node is called the pace­
maker of the heart and its fibers have a natural rate of 
about 70 impulses per minute. Prom the sinoatrial node 
the impulses pass through the atrial wall, to reach the 
smaller atrioventricular node. This node directly con­
tinues into the atrioventricular bundle (bundle of His) 
which provides a single conducting pathway between the two 
masses of contractile tissue. 
The bundle of His delivers the impulses to the ven­
tricular septum wherein the pathway divides to form the 
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right and left bundle branches. These branches carry the 
impulses to the entire endocardial surface of each ventricle. 
When an action potential occurs in cardiac muscle, 
the muscle continues to contract as long as the membrane 
remains depolarized. When the heart rate is increased the 
duration of contraction decreases almost as much as the 
rate increases. Thus the ratio of systole to diastole 
remains nearly constant at 1:2, 
The nerve supply of the heart is derived from the 
autonomic nervous system, and contains both sympathetic 
and parasympathetic elements which are antagonistic in 
function. The parasympathetic nerves (the vagi) innervate 
the atrial musculature very strongly. Acetylcholine 
secreted at the vagal endings has two major effects on 
the heart: 1) it decreases the rate of rhythm of the 
sinoatrial node and 2) it slows the transmission of 
impulses into the ventricles. The sympathetic nerves are 
supplied to all areas of both the atria and the ventricles. 
Sympathetic stimulation increases the overall activity of 
the heart in three ways: 1) it increases the rate of the 
sinoatrial node, 2) it increases greatly the force of con­
traction of all the cardiac musculature, and 3) it increases 
the excitability of all portions of the heart. 
The dynamic behavior of the vascular system itself 
can also be significantly regulated by neurogenic control. 
Sympathetic stimulation, causing a concurrent increase in 
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the smooth muscle tone of the vascular walls, increases the 
pressure at each point in an artery or vein. The opposite 
situation occurs with sympathetic inhibition. 
Two types of changes in the heart are related to 
respiration. The first is the mechanical displacement and 
change in state accompanying the movements of the diaphragm. 
The second change depends upon the indirect effect of 
altered intrathoracic pressure. Forced expiration against 
resistance raises the pressure in the thorax to a level 
above that of the blood in the extrathoracic veins, and the 
latter become distended with blood which is unable to re­
turn to the thorax. As a result of the diminished venous 
return, the heart shows an appreciable diminution in volume 
and output. Inspiration, especially forced inspiration 
against resistance, has the opposite effect and usually 
causes a sudden increase in cardiac volume and output. 
The mechanical work output of the heart is the amount 
of energy that the heart transfers to the blood while pump­
ing the blood into the arteries. Energy is expended to 
create both potential energy of pressure and kinetic energy 
of blood flow. According to Guyton (51), the work output 
required to create the kinetic energy is less than one 
percent of the total work output of the heart. The power 
requirement of the heart is about 0.005 horsepower and 
the energy for this power is derived mainly from the metab­
olism of glucose (51). Most of this energy is converted 
into heat and a much smaller portion into mechanical work. 
The efficiency of the normal heart beating under a normal 
load is around five to ten percent. 
•Cardiac Output and Venous Se turn 
Cardiac output is perhaps the single most important 
variable of the entire circulatory system, for it provides 
blood flow through all the individual organs and tissues. 
Cardiac output is considered to be the output of blood from 
the left ventricle into the aorta while venous return is 
considered to be the flow of blood from all the systemic 
veins into the right side of the heart. Cardiac output 
must be equal to the venous return over any extended period 
of time. 
Basically, cardiac output is a function of the heart 
itself, and any factor that changes the effectiveness of 
the heart as a pump also alters cardiac output. Pathologic 
factors can affect the pumping action of the heart as can 
changes in the pressure surrounding the heart resulting 
from opening the chest. 
She tifo basic means by which the heart can regulate 
its pumping action and thus its volume output are, first, 
by changing the heart rate and, second, by changing the 
stroke volume. 
Obviously any increase in heart- rate, if the stroke 
volume remains constant, causes a proportional increase in 
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cardiac output. Thus, any means for regulating the heart 
rate is also a means for regulating the cardiac output. 
As was mentioned previously, the heart rate, aside from 
its "basic intrinsic rhythm, is controlled mainly by the 
autonomic nervous system. Vagal (parasympathetic) stimula­
tion decreases the heart rate while sympathetic stimulation 
increases it. The upper limit of the heart rate for 
effectively increasing the cardiac output is about 200 
beats per minute. Above this rate ventricular filling is 
severely compromised because of a very short diastolic 
filling period. 
To "understand the regulation of cardiac output by 
changing the stroke volume, an intrinsic ability of the 
heart to adapt itself to increasing loads of inflowing 
blood should first be noted. This is called Starling's 
Law of the Heart (114). This law states that the greater 
the heart is filled during diastole, the greater will be 
the force of cardiac contraction and consequently the 
greater will be the quantity of blood pumped. This law 
can also be stated: within physiologic limits, the heart 
pumps all the blood that comes to it without allowing an 
excessive rise in venous pressure. This law forms the 
basis of the automatic control system developed in this 
study. 
Starling's law can be graphically depicted as is shown 
in Figure 3. These curves are called ventricular function 
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curves and they illustrate that the greater the volume of 
blood in each ventricle immediately before contraction, 
the greater also will be the stroke volume (51). Îîïow the 
regulation of cardiac output by means of changing the stroke 
volume can be more fully discussed. The middle curve in 
Figure 5 applies only for a constant degree of cardiac 
contractility (the vigor with which the heart muscle con­
tracts). The most important factor that can change cardiac 
contractility is stimulation of the heart by the sympa­
thetic nervous system. She figure shows that sympathetic 
stimulation increases the stroke volume at each level of 
ventricular filling, while sympathetic inhibition decreases 
the stroke volume at each level of filling. The importance 
of this neurogenic regulation of cardiac contractility is 
that it provides a means for controlling cardiac output 
separately and independently from the control of heart rate. 
The Effects of Eight Atrial Pressure 
On Cardiac Output 
Since both ventricles obey Starling's law, the study 
of the effects of atrial (or filling) pressure on cardiac 
output is very important. It is this pressure which was 
chosen as the controlling parameter to regulate the fluid 
output of the artificial ventricles developed in this study. 
Within normal physiologic limits, increasing the right 
atrial pressure increases the amount of blood that flows 
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from the right atrium to the right ventricle and consequently 
also increases the amount of blood pumped by the heart. 
The effects of right atrial pressure on cardiac output 
can be expressed in graphical form as is sho^ im in Figure 4. 
These curves are called a family of cardiac output curves. 
It can be seen from the figure that the fluid output of 
the heart, whether the heart be normal, weakened, or 
strengthened, is highly dependent upon the right atrial 
pressure. 
The effect of opening the chest on cardiac output 
should be noted. The set of cardiac output curves appli­
cable to this open-chest situation would be similar to 
those of Pigure 4 except that right atrial pressures would 
now be about four mm. Hg greater in each instance for the 
previous level of cardiac output. Unfortunately when the 
chest is opened; the right atrial pressure usually does 
not become sufficiently enhanced to maintain normal filling 
of the heart, and the heart may fail to pump adequate 
quantities of blood. 
The three most important factors that affect venous 
return are 1) right atrial pressure, 2) mean -circulatory 
pressure, and 3) resistance to blood flow through the 
systemic vessels. 
The normal right atrial pressure is approximately zero 
mm. Eg in relation to the atmospheric pressure. At this 
level the venous return is five liters per minute under 
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resting conditions. Figure 5, which is called the normal 
venous return curve, illustrates the effects of right 
atrial pressure on venous return when the circulatory re­
flexes have been completely blocked. Iifo portions of 
this curve should be explained; 
1) 2he level to which venous return can increase 
is the plateau caused by venous collapse at 
negative right atrial pressures. 
2) The venous return is directly proportional to 
the difference between the mean circulatory 
pressure (MO?) and the right atrial pressure 
(HAP) until the plateau is reached. Altering 
the mean circulatory pressure affects the 
venous return curve by causing only a vertical 
displacement from the normal curve, The shape 
of the curve remains unchanged. Also, since 
venous return can never be negative, the upper 
limit to which right atrial pressure can rise 
is equal to the mean circulatory pressure. 
Figure 6 illustrates the effects on the venous return 
curve of changing the systemic resistance, (Systemic 
resistance is the opposition to blood flow.) Venous 
return still becomes zero when the right atrial pressure 
rises to reach the mean circulatory pressure. Since the 
veins have a larger blood volume than do the arteries, the 
resistance from the veins to the heart has much more effect 
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on venous return than does arterial and capillary resist­
ance . 
Sscept for a few seconds at a time when blood is 
actually being accumulated or lost from the lungs or heart, 
venous return must equal cardiac output. Figure 7 shows 
the normal cardiac output curve superimposed upon the 
normal venous return curve. It can be seen that venous 
return and cardiac output equal each other. 
When an attempt is made to analyze the effect of some 
change on cardiac output, the effect that the change will 
have both on the ability of the heart to pump and also on 
the venous return must be considered. Then these changes 
must be evaluated together to determine the final effect 
on cardiac output. 
The effect of sympathetic stimulation on cardiac out­
put will be briefly noted. Sympathetic stimulation 
strengthens the heart and thus increases its ability to 
pump blood. Also, sympathetic stimulation augments venous 
return by principally increasing the mean circulatory 
pressure and slightly increasing the resistance to venous 
return. The combination of these tuo effects is shown in 
Figure 8 where moderate and maximum sympathetic stimulation 
are contrasted with the normal action. Points A, B, and 
C show, respectively, the equilibrium points for increasing 
sympathetic stimulation. 
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Other physiologic states, such as exercise, transfu­
sion, fever, and opening the chest, can be similarly 
analysed. Thus a large number of different factors can 
cause acute (short-term) changes in cardiac output. How­
ever, the most important factor that determines cardiac 
output is probably the need of the tissues fer oxygen. 
Oxygen utilization, then, constitutes a means of long-term 
regulation of cardiac output. 
The Function of the Veins 
The veins, once thought to be only passageways for the 
flow of blood to the heart, are capable of constricting 
and enlarging, storage of blood, propelling blood forward, 
and even helping to regulate cardiac output. 
The pressure in the right atrium is also called the 
central venous pressure. Right atrial pressure is regulated 
by a balance betirfeen, first, the ability of the heart to 
pump blood and, second, the tendency for blood to flow 
from the peripheral vessels back to the heart. This latter 
effect is a function of blood volume, venous tone, venous 
pressure gradient, and by dilation of the systemic small 
vessels. The normal right atrial pressure is approximately 
zero mm. Hg but can change in various pathologic states 
from -4 mm. Hg to as high as +20 mm. Hg. 
The large veins have almost no resistance when they 
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are distended. Since this is not normally the case, the 
large veins usually do offer considerable resistance to 
blood flow. Thus pressures in the peripheral veins 
are usually six to nine mm. Hg greater than the right 
atrial pressure. When the right atrial pressure rises above 
its normal value, blood begins to accumulate in the large 
veins thus distending them. However, the pressures in 
the peripheral veins do not rise until all the collapsed 
points between the peripheral veins and the large veins 
have opened up. 
Hydrostatic pressure affects the values of venous 
pressure in the peripheral veins, from a value of +90 
mm. Eg in the feet to -10 mm. Eg in the sagittal sinus of 
the head. However, the right atrial pressure still remains 
approximately at its normal value. The veins have small 
one-way valves in them that help in moving the blood 
centrally. These valves are passive and are activated by 
the flowing venous blood. This venous pump is so effi­
cient that, under ordinary circumstances, the venous pres­
sure in the feet of a walking adult is less than +30 mm. Eg. 
Physiologically, there is one point in the circulatory 
system at which hydrostatic pressure does not affect the 
blood pressure measurement by more than one mm. Hg. This 
point is at the level of the tricuspid valve as is shown 
in Figure 9. Therefore all pressure measurements are 
referred to this level which is called the reference point 
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for pressure measurement, The reason for the lack of 
hydrostatic effects at the tricuspid valve is that the 
heart automatically prevents any significant variation 
in pressure at this point by appropriate changes in its 
cardiac output and filling capacity. In venous pressure 
measurements the reference level must be very exact if the 
measurements are to be significant; for very small varia­
tions in venous pressure result in great changes in 
cardiac output. 
Approximately 50 percent of all the blood in the 
circulatory system is in the systemic veins (51). Thus 
the veins act as a blood reservoir for the circulation. 
An extremely important function of this venous reservoir 
is its ability to change both its volume and the rate at 
ivhich blood is returned from the peripheral vessels to 
the heart. Sympathetic stimulation of the venous reser­
voir, for instance, can elevate venous return and cardiac 
output up to as much as two and one-half times normal. 
Increased venous return due solely to venoconstriction, 
however, terminates when excess volume is transmitted to 
the heart. Then the effects of increased cardiac output 
through the system maintain the elevated flow rate. 
Regulation of Arterial Pressure 
The arterial pressure is normally regulated at a level 
much higher than is needed to provide normal blood flow to 
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th.e tissues. This allows the tissues to suddenly increase 
their blood flow by locally dilating their arterioles. The 
systolic pressure of a normal young adult averages about 
120 mm. Hg, while the diastolic pressure averages about 
80 mm. Hg. The mean arterial pressure is the average pres­
sure throughout the cardiac cycle and it averages about 
96 mm. Hg. 
An analog can be made for the pressure-flow character­
istics of a vascular area by using the voltage-current 
relationship of an electrical resistor. The voltage drop 
across the resistor equals the current through the resis­
tor times the resistance. For the entire body then, blood 
pressure equals cardiac output times total peripheral re­
sistance. Thus the body can control its mean arterial pres­
sure by changing either the cardiac output or the total 
peripheral resistance. One of the most important functions 
of the arterioles in the circulation is the regulation of 
peripheral resistance. 
There are three chief methods by which the arterial pres­
sure is normally regulated. Each method operates at least 
partially independently of the other two and each has spe­
cific capabilities for keeping the arterial pressure regula­
ted at a constant value. These methods are the following: 
1) regulation by the autonomic nervous system 
2) regulation by the kidneys 
3) regulation by the endocrine glands. 
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The nervous system is extremely important in regulating 
arterial pressure in the head and in conditions of sudden 
crises. This method is fast acting but tends to adapt 
and thus its usefulness in long-term regulation of arterial 
pressure is limited. Renal regulation of arterial pressure, 
which includes a capillary fluid-shift mechanism, is slow 
to react but maintains almost constant arterial pressure. 
Renal regulation is the best long-term control mechanism. 
The endocrine glands also constitute a means of long-term 
regulation of arterial pressure. The action of the 
endocrine system is complementary to the actions of both 
the nervous system and the renal system. 
The operating features of these three methods are dis­
cussed in Guyton (52). It should be obvious that these 
methods are eztracardiac and thus still should be active 
with an artificial heart in place. 
Several other factors concerned with the control of 
mean arterial pressure by the nervous system should be 
mentioned. The intensity of sympathetic activity of the 
vasomotor center in the brain increases almost directly in 
proportion to the concentration of carbon dioxide in the 
extracellular fluids bathing this center. Thus, carbon 
dioxide is one of the most powerful of all stimuli affecting 
the activity of the vasomotor center which, in turn, affects 
the arterial pressure. 
25 
Respiratory modulation of the arterial pressure is a 
less important circulatory reflez. The modulation is 
caused both neurogenically and by mechanical actions of 
the lungs and diaphragm. 
Blood Volume 
The average blood volume of a 70 kilogram adult is 
5,000 milliliters. Approximately 2,750 milliliters of this 
blood is plasma, and the remainder, 2,250 milliliters, is 
red blood cells. The percentage of red blood cells in the 
blood is called the packed cell volume (POY) and is normally 
40 for a man and 56 for a woman. 
The percentage of the total blood volume in each por­
tion of the circulatory system is (51): 
Large veins 25 
Small veins, venules, 
and venous sinuses 25 
Heart 18 
Pulmonary vessels 12 
large arteries 8 
Small arteries 5 
Arterioles 2 
Capillaries 5 
The term vascular capacity is used very loosely to 
mean the amount of blood that the circulatory system will 
hold. Since the mean circulatory pressure is somewhat 
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proportional to the ratio of blood volume to vascular 
capacity, it can be seen that the volume must be precisely 
regulated so that it will always fill the circulatory system 
up to approximately the same constant pressure. 
The compliance of the circulatory system is the 
change in blood volume that can be accommodated in the 
circulatory system for each unit change in pressure. From 
pressure-volume curves of circulatory systems it can be 
shoi-m that the relationship between blood volume and mean 
circulatory pressure (MOP) is 
Blood Volume = + (MO?) (dv/dp) 
where is the blood volume of the circulatory system 
when MOP is zero and (dv/dp) is the compliance of the cir­
culatory system (52). 
The blood volume is regulated by several different 
mechanisms, each one having its own special capabilities. 
The plasma volume can increase and decrease markedly in 
very short periods of time to regulate the blood volume in 
accordance with the needs of the circulatory system. A 
capillary fluid-shift mechanism allows relatively rapid 
loss of fluid from the circulation into the interstitial 
fluid whenever the blood volume becomes too great. How­
ever this mechanism does not return the blood volume all 
the way back to normal. The final volume adjustment is 
caused principally by kidney action. This renal mechanism 
27 
may require a day or more for blood volume adjustment, in 
comparison with, minutes to hours for the capillary fluid-
shift mechanism. • 
The total volume of red "blood cells is very slow to 
change. The red blood cell volume is regulated almost 
entirely independently of the total blood volume. The 
volume of cells is regulated primarily to provide adequate 
oxygen transport to the tissues. The plasma volume is 
then adjusted accordingly to finish filling the circulatory 
system. 
The Pulmonary Circulation 
A minute quantity of blood flows through the bronchial 
arteries and returns to the left atrium instead of to the 
right atrium. Thus 1) the quantity of .blood flowing 
through the lungs is greater than that flowing through the 
systemic circulation and 2) the quantity of blood flowing 
through the left side of the heart is greater than that 
flowing through the right side. The difference in flow 
amounts to, on the average, about one percent (51). 
The pulmonary arteries and veins are all very short 
and do not accommodate nearly so much blood as do their 
counterparts in the systemic circulation. The blood in 
\ 
the pulmonary arteries is verious blood and that in the 
pulmonary veins is arterial blood. 
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The mean pulmonary arterial pressure' averages approx­
imately 13 mm. Eg in the normal human while the pulse 
pressure averages approximately H mm. Eg. The mean pres­
sure in the left atrium and in the major pulmonary veins 
averages approximately four mm. Eg. Thus the normal pres­
sure gradient between the mean pulmonary arterial pressure 
and the left atrial pressure is nine mm. Eg. #hen the left 
atrial pressure rises, the pulmonary arterial pressure 
also rises almost an equal amount with the pressure gradient 
falling only slightly. The right ventricle is able to 
compensate for the increased load. Variations in nervous 
activity also often aid the right ventricle in load compen­
sation. 
The cardiac output can increase to three to four times 
normal before the pulmonary arterial pressure begins to 
rise markedly. This is caused by the fact that the pulmonary 
vessels are normally partially collapsed and can easily 
tolerate large increases of flow rate. This mechanism 
conserves much energy if both the blood flow and rate of 
gaseous exchange must increase suddenly. 
The quantity of blood that flows through the lungs is 
controlled almost entirely by the pumping ability of the 
heart and by the return of blood to the heart from the 
systemic circulation. The pulmonary vessels are mainly 
passive tubes. Eowever, the larger arteries of the pulmonary 
system are supplied with smooth muscle weakly innervated 
by both cholinergic "&&&_ serve fio&rs ancL acir 
sympathetic fibers. i'his innervation is responsible for 
very minor vas on..::; or roaoticna union oan occur in the lungs, 
The blood voluno in all the vossels of the t?;o lungs 
is approninately 600 to SCO nillili'^srs in the average 
human (51). un^er oiffsront phyciologio conditions, the 
quantity of blood in the lungs can vary from about 50 
percent of normal up to ;00 percent or more greater than 
normal« Since the volume of the systemic circulation is 
about seven times greater than the volume of the pulmonary 
circulation, the shift of blood from one circulation to 
the other affects the lungs greatly but usually has only 
mild systemic effects. 
5he Coronary Circulation 
tne ^efu coronary artery supplies mainly 
the left ventricle and ';he right coronary artery supplies 
mainly the right ventricle. Most of the venous blood from 
the left ventricle leaves by ^-ray of the coronary sinus and 
most of the venous blood from the right ventricle flovrs 
through the small anterior cardiac veins v:hich empty direct­
ly into the right axrium. 
The coronary blood flo'-r is appromimately four percent 
of the total cardiac output. In humans this is about 225 
milliliters per minute. She blood flo'-r rate through the 
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capillaries supplied by the left coronary artery falls to 
a very loif value after the first third of systole is over. 
Then during diastole, the cardiac muscle relaxes completely 
and no longer obstructs the flow of "blood through the 
capillaries. Therefore, blood flows very rapidly through­
out most of diastole. 
Blood flow through the coronary circulation is regu­
lated almost entirely by a local mechanism in the heart in 
response to the needs of the cardiac musculature for 
oxygen. This mechanism works equally as well whether the 
nerves to the heart are intact or removed. It is believed 
that oxygen lack dilates the coronary arteries to increase 
the coronary flow rate (52). However, stimulation of the 
sympathetic nerves to the heart can increase coronary blood 
flow several times, while parasympathetic stimulation can 
decrease coronary flow by perhaps 20 to 50 percent. Yet, 
it is believed that these results occur secondarily to 
other effects of nerve stimulation. 
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ESYIEW OF THE LITEHATUHE 
Ideal Specifications 
A substitute for the natural heart must simultaneously 
satisfy a combination of difficult requirements. Naturally 
most of the requirements are fundamental to normal heart 
action. 
Some properties mechanically mimic the normal heart. 
1) Blood should progress in one direction only. 
2) Blood should "be expelled "by a squeezing motion in 
order to minimize blood trauma. 
3) The systolic residue (end-systolic blood volume) 
should remain in the central lumen in order to 
minimize turbulence. 
4) Circulatory stasis (stagnation) should be avoided 
in order to prevent clotting. 
5) The pump should function quietly and reliably for 
long periods of time. 
The following properties physiologically mimic the 
normal heart. 
6) The prosthesis should be an effective hemodynamic 
support for the circulation by being capable of 
providing a cardiac output adequate to meet the 
metabolic demands created by a reasonable level of 
activity. 
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7) The prosthesis should preferably respond to the 
physiologic control mechanisms which normally 
maintain hemodynamic equilibrium. 
8) The pump should include automatic control of cardiac 
output to be responsive to the body's demands for 
blood, 
9) The flow rate should be adjustable from zero to at 
least five liters per minute (44). 
10) The pump should not have a fixed stroke volume. 
11) The pump should fill even at low negative pressures. 
12) ?or adequate filling diastole should be longer than 
systole. 
13) The pump should maintain adequate perfusion pres­
sure at no expense to venous pressure (54). 
14) The mechanism should produce pulsatile flow and 
should be capable of being adjusted in pulse rate 
and stroke volume independently (44). 
15) The presence of the pump should not interfere with 
the body's normal physiology or activities and 
should in no way compromise remaining cardiac 
functions. 
The problems of tissue reaction, blood trauma, and 
clotting must be reckoned with. Selecting the proper mate­
rials is extremely important. 
16) The rate of hemolysis produced by the prosthesis 
must not only be within the body's capability for 
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removing the products of hemolysis, but also below 
the rate of cell destruction which will give rise 
to a progressive anemia, i.e., the blood constit­
uents should be destroyed at rates smaller than 
those which characterize their production (16). 
17) The pump should be compatible t-rith other body 
tissues and should not provoke the hazards of 
infection and tissue reaction. 
18) Local turbulence in entrance and ezit zones and 
around necessary valves, branches, and other con­
strictions should be minimized. 
19) The pump should have minimal chances of immediate 
or latent hemorrhage. 
20) The pump should require no heparin or other anti­
coagulants while functioning — at least to the 
point that normal clotting mechanisms would not 
be significantly altered (54). 
21) The materials used and the geometric design chosen 
must be such as to minimize the tendency toward 
clot formation. 
22) There should be minimal contact of blood with 
foreign materials and the blood containing compo­
nents should be smooth and nonwettable. 
23) Surfaces in contact with blood should not touch or 
r 
occlude during operation (1), 
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24) The pump should be fabricated of. strong and .. 
durable material — rigid material should be 
avoided where possible (54). 
25) Stress in all moving parts should be minimal and 
uniform (1). 
factors such as size and weight, power and efficiency, 
and costs of both manufacture and operation must be con­
sidered. 
26) The pump should have space and design requirements 
which would not compromise adjacent organ struc­
tures . 
27) The pump should be lightweight. 
28) The pump should operate at relatively high 
efficiency in order to minimize the power require­
ments and thus make operation independent of fized 
power sources. 
29) In the event of any power failure, the unit should 
be capable of manual operation. 
30) There should be minimal heat production by the 
artificial pump. 
31) The design should lend itself to standard fabrica­
tion techniques so that many units could be built 
without extensive tooling and yet retain as much 
flexibility for design changes as possible. 
32) Initial cost should be reasonable and maintenance 
cost low. 
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Finally, installation, operation, and safety must be 
taken into account. 
33) There should be a reasonably simple surgical proce­
dure for insertion in as short a time as possible. 
34) There should be a physiologic access plug to 
facilitate connection of the pump to an extra­
corporeal power and control system. 
35) Pumping adjustments should be simple to make and 
settings should remain fixed for uniform performance. 
36) The system should possibly allow for pumping syn­
chronization with the variable atrial rate, unin­
fluenced by both movement due to physiologic proc­
esses and electrical interference from the outside 
(91). 
37) The pump should be completely safe to use — it 
should not jam, skip beats, burst, or leak. 
38) The unit should be so designed that malfunctioning 
could be quickly detected, diagnosed, and possibly 
corrected. 
If a majority of these conditions are realized, it is 
very probable that individuals with such prostheses could 
engage in reasonably normal social activity and occupation. 
Types of Pumps Developed 
A variety of pumps have been used with various types 
of oxygenators in extracorporeal circulation units. Many 
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of these pump designs have been carried over into the 
development of Intrathoracic artificial hearts. The pimps 
most frequently used have been the roller, the finger, and 
the diaphragm type. The dual-roller blood pump continues 
to be employed in most extracorporeal blood circuits de­
spite the fact that a number of pumps have been designed 
that are capable of propelling blood with less trauma (44). 
Pumps which are less traumatic usually consist of ventricles 
which are compressed externally by hydraulic or pneumatic 
force. 
The operation of a roller-type pump is quite simple. 
A flexible tube carrying the fluid to be pumped is secured 
in a circular frame. A rolling cylinder moves along the 
tube thus squeezing the tube between the cylinder and the 
frame. This moving occlusion then pushes the fluid through 
the tube. With regard to the advantages of one versus two 
(or more) rollers in a blood pump, it has been shoifn that 
increasing the number of rollers and therefore reducing 
the stroke volume increases hemolysis for a given volume 
of blood pumped (4$). Esmond ejt (44) developed a single-
roller blood pump which used the minimum force needed to 
just occlude the tubing. This pump produced very low 
hemolysis rates b,ut was intended for extracorporeal use only, 
Pierson ^  al. (101) investigated the use of a small 
lightweight roller pump to achieve acceptably low hemolysis 
rates. Their high speed, partially occlusive pump operated 
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at outputs in the range of two liters per minute. 
The shortcomings of roller pumps and of conventional 
round tubing for long-term blood pumping are interrelated. 
Relatively high degrees of occlusion and/or high speed are 
required in order to minimize baokflo#. Backflow tends 
to produce turbulence which in turn induces hemolysis. Also, 
appreciable hysteretic power losses are inherent with a 
round cross-section because of the high deformation 
accompanying the 85 to 100 percent occlusion usually re­
quired. 
A pump and tubing device has been designed which com­
bines certain advantages of valved pumps with the structural 
and operational simplicity of roller pumps (100). The 
principal design innovation in this low-powered and read-
ily-miniaturized pump was the use of flat rubber tubing 
whose interior was segmented into small chambers by thin • 
leaflet bicuspid valves. Eaokflow was avoided and rela­
tively high volumetric pumping efficiencies were obtained 
at low degrees of occlusion. This design represented 
efficient use of input power. 
The fluid-actuated heart pump has seen little use in 
extracorporeal pumping circuits. However it is still a very 
popular type of pump because of its use in many artificial 
heart designs. It is characterized by low weight, high 
reliability, low heat production, and low hemolysis (59). 
The outstanding feature of such a pump, nfith an external 
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control system, is that great flexibility of operation is 
possible without any adjustments of intrathoracic components. 
A fluid-actuated artificial heart pump is shown sche­
matically in Figure 10, If the controlled actuating fluid 
pressure is reduced to a value lower than the venous re­
turn pressure the moving element (rolling or stretched 
diaphragm, collapsing bag, or reciprocating piston) will 
travel to the left. The inlet valve will open and a volume 
of blood will be accepted by the pump. If Pj is then in­
creased to a value greater than the arterial pressure 
the moving element will travel to the right. This action 
closes the inlet valve, opens the outlet valve, and forces 
the volume of blood into the arterial system. Causing Pq 
to pulsate according to some repetitive waveform will per­
mit continued pumping of the heart. 
Both air- and liquid-actuated hearts have been built, 
with the former type being the most popular. Hastings 
et al. (56, 57) pursued the development of a liquid-driven 
artificial heart. They devised a two-chambered, hydrauli-
cally-activated diaphragm pump. 
The Cleveland Clinic's Department of Artificial Organs 
has been very instrumental in the development of air-driven 
artificial hearts. The fabrication, testing, use, and con­
trol of their artificial pumps have been well documented., 
Important publications by this group are the ones directly, 
concerned with air-driven artificial hearts ( 4, 5, .6, 88, 
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92, 94, 110, 111), those dealing with methods of power and 
control (58, 59, 06, 96), and finally those discussing the 
testing and the damaging tendencies of their various pumps' 
(23, 29, 59). Several of the Clinic's staff have written 
excellent treatises on the problems encountered in artifi­
cial heart development (63, 64, 89). 
Several pumps have been designed to specifically over­
come certain inherent problems common to most artificial 
hearts. One of the problems is that of suction, which is 
not a normal feature which aids in ventricular filling 
during diastole. Under normal conditions, about one-half of 
the stroke volume enters the ventricle at the beginning of 
diastole. The area of the mitral valve shifts upward and 
"engulfs" the blood that has accumulated in the atrium 
during ventricular systole. To prevent suction from occur­
ring, a rather large sliding pump that duplicated this en­
gulfing action was devised (103). Another way to obtain 
an adequate stroke volume with minimal suction in a dia­
phragm-type pump is to make the pump flat and thus have a 
large membrane area. Using this idea, liotta et s^, (79) 
developed a membrane-type pump in which systolic residue, 
filling time, and the amount of suction pressure were easily 
controlled. 
A second and more serious problem inherent in any blood 
pumping device is that of hemolysis. In an attempt to 
alleviate this problem, an unconventional artificial heart 
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using only a single ventricle %fas developed (99). In this 
system a biologic circulatory bypass replaced the right 
ventricle and thus eliminated one pump. îhe system's main 
features ware its advantages over the conventional two-
ventricle artificial hearts — less blood damage» fewer 
valves, smaller size, greater reliability, and decreased 
energy requirements. 
A rather novel artificial heart employed a flezing 
piezoelectric crystal (8o). The use of this material per­
mitted a direct and efficient conversion of electrical energy 
to pumping energy. 
Second in popularity to fluid-driven artificial hearts 
are those hearts which use small integral motors to provide 
the pumping power. Their main advantage is in their con­
trollability in that the fluid output is almost directly 
proportional to motor speed. Houston _et (60) developed 
an a-c motor-driven two-ventricle artificial heart. The 
motor, through a gear reduction system and a set of pivots 
and eccentrics, sïfung back and forth within a rigid housing. 
The body of the motor alternately compressed each ventricle 
against the housing thus expelling its contents. This pump 
exhibited both low hemolysis and some degree of automatic 
regulation via atrial pressure changes. 
Akutsu _et sj. (3) developed a similar d-c motor-driven 
heart in which the motor drove a small freely moving roller. 
The roller rotated within a brass housing in which there 
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vers two poljurethane ventricles. The ventricles pumped 
alternately. This pump also showed low hemolysis and some 
degree of automatic regulation. 
The extracorporeal roller pump is not without its 
miniaturized intrathoracic equivalent (101). Small motor-
driven pis ton-type blood pumps have also "been built (24, 
62, 97). A flat pancake-type d-c motor was built into the 
base of a piston pump (99). A set of cams and gears con­
verted the rotary motion to pulsatile motion. This motor 
consumed very little power — 10 watts. 
A variation of the piston-type pump, developed by Burns 
et al. (28), was versatile in that both the pulse rate 
and the pressure waveform could be varied independently. 
This same group later reported on the development of another 
motorized heart in which the motor provided power to an 
hydraulic fluid (27). The fluid, when properly controlled 
by internal valves, did the pumping work. 
The electromagnetic solenoid has also been employed to 
actuate the moving element of an artificial heart. Kolff 
(65) utilized several small solenoids in his initial artifi­
cial hearts. 
Materials 
The choice of materials for a mechanical heart is based 
on a number of factors, but prime consideration is given to 
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long mechanical life and non-destruction of the blood ele­
ments. 
Consideration of the problem of long-term survival with 
an artificial heart indicates that one of the primary prob­
lems to be solved is the prevention of clot formation 
either in the prosthesis or in a natural vessel of the body. 
Savryer (105) has stated that efforts dedicated to the fabri­
cation of mechanical blood pumps will be unsuccessful until 
there is made available a plastic which reacts to blood as 
does the normal vascular intima. 
Pumping blood with a mechanical, implantable device 
made of impervious plastics invariably leads to the deposi­
tion of a blood protein onto the luminal surfaces of the 
device. Such a deposition has been observed on many useful 
plastics, such as methylmethacrylate, polyurethane, silicone 
rubber, lucite, teflon, and silk (79). Liotta ejfc (74) 
have found that soon after such pumps begin functioning, the 
unattached film of blood protein, which varies in thickness, 
is observed on the luminal surfaces of both the inlet connec­
tors and the blood chamber, later it appears disintegrated 
and accumulated at valves or embolized into the arterial 
system. The propensity for thrombus formation is not iden­
tical in all animals. It is generally agreed that the prob­
lem of thrombosis on a prosthesis is much more severe in the 
canine heart than in the human heart (48). 
Considerable research has been carried out by a number 
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of investigators on the relation between blood coagulation 
and the material in iiamediate contact with the blood. Gott 
et al. (49) have been able to obtain an antithrombogenic 
surface using a graphite-benzalkonium chloride-heparin coat­
ing. 
Velour fabric was found to be an excellent blood-
contacting surface (74), The velour-type liner fosters 
development of a strong, permanent mechanical bond between 
the plastic and the internal fibrin lining. Trapped and held, 
this coagulum forms an autologous lining within the pump, 
protecting the blood from further contact with the foreign 
material. Once this formation has been achieved, the blood-
plastic interface within the mechanical pumping system no 
longer exists and chances of dissection and embolization are 
negligible. 
Liotta ^  (74) have been instrumental in the use 
of this material and have achieved rewarding results. They 
reported that, during pumpingj plasma hemoglobin levels fell 
to preoperative values and a prolonged patency of the me­
chanical system was achieved. They found that pumps lined 
with nylon velour fabrics demonstrated the best fibrin attach­
ment and dacron velour was second. They stressed, however, 
that a satisfactory pseudoendocardium could be obtained only 
if the pumping chamber was properly designed, the valves 
were so placed so as to eliminate areas of stagnation, and 
a high hemodynamic condition was maintained throughout the 
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mechanical pumping system. They also emphasized that the . 
mechanical characteristics of a material were as important 
as its chemical composition. 
The main mass of most artificial hearts has been fab­
ricated from lucite, silicons rubber, or natural latex 
rubber. The majority of these have used a medical grade of 
silicone rubber which has usually been reinforced with a 
woven material. Silicone rubber is a synthetic material 
which is minimally reactive when in prolonged contact with 
blood. 
Size and weight factors can also influence the choice 
of materials. A comparison has been made on a weight basis 
of normal and artificial hearts. If the normal heart weighs 
400 gramsJ then a natural rubber artificial heart with the 
same pumping capacity weighs 350 grams; a silicone rubber 
heart, 650 grams; and a fluid amplifier heart, 800 grams 
(92). 
Artificial ValvêB 
Artificial heart pumps, which function by the intermit­
tent compression of a chamber by air or fluid require valves 
in the inflow and outflow tracts to ensure unidirectional 
flow. 
The valve designs used in artificial hearts are mainly 
outgrowths of the various types of valves used in replacing 
diseased heart valves in humans. The two most common ones 
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are the ball valve and the flap or leaflet valve. Valves 
made with cusps and other types which physically duplicate 
the actual heart valves have also been used. 
Oartvrright ^  al. (52) give a short history of the 
development and use of ball valves along with a description 
of a newer ball valve of their own design. Because of rel-
atively large size requirements, ball valves have been used 
less and less in the later artificial heart designs. Leaflet 
valves are smaller and lighter in weight, operate with less 
mechanical movement and pressure gradient, and are less 
sensitive to gravity effects than are ball valves. Thus 
their use is becoming more prevalent not only in artificial 
hearts but also in human hearts with malfunctional valves. 
The formation of thrombi on artificial valves is prob­
ably the greatest obstacle to their successful application in 
artificial hearts, since fibrin deposits are very common on 
and around the valves. Deposits form rapidly in any stagnant 
area. Akers £t (1) have found that the discharge side 
of leaflet valves in the aortic position quickly develop 
large fibrin deposits, and that these deposits initiate at 
any joint or roughness in the surface. Mirkovitch _et al. 
(86) indicated that only plastics with smooth surfaces, sus­
pended in the middle of the blood stream, and without direct 
or extensive contact with tissue stay free of thrombi. They 
also set forth some rules for the design of an artificial 
valve : 
1) The leaflets of the valve should have a smooth 
surface. 
2) The leaflets should be exposed to a strong, moving 
blood stream. 
3) Eo small or motionless pockets filled with stag­
nant blood and no narrow commissures should be 
present. 
4) The valve parts should exhibit minimal friction 
with each other. 
Naturally, the criteria by which the artificial valve is 
judged are based on how well it approximates a normal, nat­
ural valve. 
Dreyer _et ( 3 9 )  give further necessary specifications 
for valves to be used in artificial hearts: 
5) The valve should not induce the deposition of fi­
brin. 
6) The valve should be atraumatic to the constituents 
of the blood. 
7) The valve should be very durable and exhibit a 
long mechanical life. 
8) The valve should be completely competent during 
the closing phase. 
9) The valve's action should be swift. 
1 final requirement is that of low forward resistance 
to the flow of blood. This is especially important on the 
input side to obtain a sufficient venous return. If the 
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inflow valve resistance is low the artificial heart will 
function according to Starling's law (92). But when the 
inflow resistance is high, the atrial pressure required to 
fill the ventricle must also be high and suction may be 
necessary. 
Probably the most critical aspect of a flap or leaflet 
valve is the selection of a satisfactory leaflet material. 
The valve leaflet has to be very flexible so that it can 
open with a small pressure gradient and yet have the 
strength and stiffness so that it can withstand a high back 
pressure (140 mm. Eg maximum). Gott ^  (48) tested many 
leaflet materials and found polyvinylfluoride to be the most 
successful plastic film.' They coated some of their plastic 
surfaces with colloidal graphite and found a very definite 
reduction in clot formation. Colloidal graphite is ex­
tremely non-wettable, conductive, and chemically inert and 
it is a very smooth surface. 
In 1964, Gott et al. (49) described a new type of anti-
thrombogenic coating which contained graphite, benzalkonium, 
and heparin (GBH). The important antithrombogenic property 
of graphite is that it has the ability to bond firmly a 
cationic surface agen€"(benzalkonium), which in turn can 
bond heparin. They obtained routine long-term survival of 
dogs with GBH coated prosthetic valves, 
Gott ejt sj. (43) have also designed a flap valve con­
structed of a rigid plastic housing and a flexible 
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"butterfly-ving" leaflet. TMs valve was subsequently GBH 
coated and has becoES a very popular prosthesis for human 
heart valves. 
Aside from the thrombosis problem, the other major 
concern in valve design is that of hemolysis (blood cell 
trauma), jiv'unn et al. (95) have indicated that diaphragm 
and other compression-type artificial hearts cause little 
cell damage. The actual degree of hemolysis is largely 
dependent upon the type of valves employed. They performed 
a study to determine the relative amounts of hemolysis 
caused by three types of valves (flexible tricuspid, 
"butterfly", and ball) suitable for use in air- or fluid-
driven artificial hearts. They established that all valves 
tested showed a linear increase in plasma hemoglobin pro­
duction as pumping time increased. Akers _et (1) found 
that the rate of hemolysis was almost directly related to 
the pulse rate and was only slightly affected by flow rate. 
They showed that leaflet, tricuspid, and soft disk valves 
had the lowest rates of hemolysis, ball-type valves were 
intermediate, and hard disk valves were the highest. With 
regard to backflow, this same study found that it was highest 
in ball-type valves, intermediate in disk-type valves, and 
lowest in leaflet and membrane valves. 
All artificial valves should be tested in a mock 
circulatory system to ascertain their performance, Dreyer 
et al. (39) and Steinmetz ^t alt- (115) describe mechanical 
systems to carry out such tests. The latter group has 
developed an accelerated fatigue machine which can subject 
a valve to physiologic pressure variations at rates up to 
2J500 cycles per minute. 
Blood Trauma 
Any serious effort at prolonged mechanical support of 
the circulation must consider the biologic tolerance to 
continuing damage imposed by the support system. Such 
damage includes the immediate breakdown of red blood cells, 
the presence of the envelopes of the cells in the circula­
tion, and other, more subtle, forms of damage to the blood 
cells #hich may impair their ability to survive or function 
over a normal life span (12). This damage is one obstacle 
which precludes the continuous use of mechanical circulatory 
support systems for periods of unlimited duration (70). 
Hemolysis, or the separation of the hemoglobin from 
the corpuscles and its appearance in the fluid in which the 
corpuscles are suspended, is the usual way of measuring the 
degree of trauma inflicted by artificial pumps, and valves. 
She presently accepted method of reporting hemolysis is 
the index of hemolysis (I.H.) (118). This index is deter­
mined by the total production of free plasma hemoglobin 
divided by the number of passages the blood has made through 
the device: 
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Where E^ = final plasma hemoglobin (grams per liter) 
Eg = initial plasma hemoglobin (grams per liter) 
P = flow rate (liters per minute) 
T = time (minutes) 
V = priming volume (liters) 
The units on the indez of hemolysis are grams of free hemo­
globin released per 100 liters of blood pumped. Esmond 
et al. (44) have stated that the pumping rate and the pres­
sure against which the blood is pumped must be given for 
this index to have significance. 
Wesolowski (118) indicated that repeated passages 
through a given pump at a given flow led to a linear in­
crease in production of free plasma hemoglobin and thus 
there was apparently no great summative effect of the same 
red cell having been traumatized twice by the pump. This 
suggests that hemolysis may be an all or nothing effect for 
any particular red cell. This group found that free hemo­
globin production was a function of the flow rate whereas 
Akers ejt a2. ( 1 ) indicated it was a function of the pulse 
rate. Eowever, these two factors are interrelated since flow 
rate equals cardiac output (liters per beat) times pulse rate 
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(beats per minute). 
In naking coiapariscns betweea the degree of hemolysis 
caused by different pumps, the test circuit should be en­
tirely vitro. The reason that an animal should not be 
in the circuit is that free hemoglobin is -withdrawn from 
the circulation continuously by the kidneys, liver, and the 
reticular-endothelial system and the rate of removal varies 
from animal to animal (117). Therefore, the actual meas­
urement of free hemoglobin in the circulating plasma is not 
a true measure of the cellular destruction. It has been 
found that htimans, not- in a s-tate of dehydration or shock, 
can clear doses of up to 14 grams of free hemoglobin within 
24 hours if they possess normal renal function (12). It 
should be pointed out that red cell destruction is a normal 
event in animals. In a 70 kilogram human, blood is de­
stroyed at the average rate of 0.093 milligrams for every 
100 milliliters of blood circulated (44). 
Plasma hemoglobin measurements, however, do not tell 
the whole story about trauma to red cells. Kusserow ^  all 
(71) suggested that prolonged circulations with reasonably 
atraumatic blood pumps resulted not only in the outright 
or prompt destruction of a certain fraction of the red cells 
initially present, but also in the infliction of signifi­
cant damage on other erythrocytes short of outright de­
struction, followed by premature senescence of the cells 
and anemia. Since these abnormalities also do not show up 
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in vivo tests, vitro studies of the mechanical fragil­
ity of cells are very important (23). 
Most prosthesis-development groups have tested their 
devices for degrees of hemolysis. Pierson _et (101) 
stated that fresh heparinized blood should be used within 
four hours of extraction from an animal for the hemolysis 
studies. Their small motorized roller pump gave an indez 
of hemolysis of 0.17 to 0.29 with canine blood. Using an 
improved version of their roller pump, this same group, later 
reported an indez of hemolysis of 0.35 with human blood 
(100). The pumping system devised by Kusserow and Clapp 
(Ô9) gave an index of hemolysis at a flow rate of 1225 
milliliters per minute of 0.08 with fresh heparinized canine 
blood in a 0.5 liter capacity system. Castaneda, _et al. 
(55) reported an index of hemolysis of 0.08 to 0.18 at flow 
rates of 1.5 to 3.5 liters per minute with the army heart 
pump. 
Other Problems Associated 
With Artificial Hearts 
An artificial heart is a prime example of a homeo-
stasis-maintaining artificial organ which experiences and 
provides for the flow of blood in it while transferring 
mechanical energy to the blood. To guarantee its intended 
purpose, the blood handling must be achieved under atrau­
matic physical and chemical conditions. 
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I^îany artificial blood pumps presently being used are 
too toxic for prolonged use because they destroy the formed 
elements in the blood. Leonard (72) stated that the primary 
cause of mechanical degradation appeared to be shear forces 
exerted on a particle in a region with a high fluid velocity 
gradient. However, Salisbury et al. (103) believed that 
the functional disadvantages were due not only to turbulence 
but also to negative blood pressure during the filling 
phase in the pumping chamber and to crushing of blood cells 
between opposing surfaces. 
It appears that there are distinct advantages in having 
an artificial heart produce a pulsatile blood flow, The 
evidence suggests that pulsatile flow is important not only 
in the design of an artificial heart but also during long-
term extracorporeal circulation. Burns, et al. (28), in a 
series of tests found that both systemic and pulmonary 
vascular resistance increased (125 percent and 127 percent, 
respectively) with non-pulsatile flow as compared to pulsa­
tile flow. Further, they indicated that this resistance 
change was unaffected by sympathetic or parasympathetic 
blockade, nephrectomy, or baroreceptor denervation. It is 
also possible that unphysiologic pressure curves generated 
by an artificial ventricle, even though they be pulsatile, 
might harm the lungs and the systemic vascular bed. Fortu­
nately, the elastic aorta will compensate for a great deal 
of abnormality in the aortic waveform (89). Sose et al. 
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(94) found that if the air pressure driving a pneumatioally-
povered ventricle had a high, sharp initial peak, then the 
pulmonary arterial blood pressure attained a desirable wave­
shape. 
If sufficient venous return is to be obtained with 
artificial hearts, a proper circulating blood volume is 
necessary. Low blood volume also leads to poor arterial 
blosd pressures. In many artificial heart trials by many 
groups, the blood volume had a tendency to decrease in the 
course of pumping, regardless of transfusion to replace 
the blood loss. In a series of experiments using an extra­
corporeal artificial heart, Atsumi et (9) found that 
1) total vascular resistance decreased to about 70 percent 
of the initial level after one hour of circulation, 2) 
after three hours, the circulating blood volume had decreased 
to 67 to 75 percent of the initial value, and 5) blood pool­
ing occurred mostly in the mesentery, intestine, and liver. 
l-Ioss et (92) found that both blood pH decreased and 
ascites formation occurred under conditions of low flow and 
poor venous return. ïhey also stated that low molecular 
weight dextran was a useful infusion for increasing venous 
return, atrial pressures, and thus cardiac output. 
Venous return is also aided by proper operation of 
the lungs. During normal inspiration the negative intra­
thoracic pressure tends to increase the venous return to the 
right heart. The increased volume of the lungs during 
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inspiration allows this increased flow to be accommodated ' 
with no increase in pulmonary artery pressure. On expiration 
the less negative intrathoracic pressure causes the venous 
return to the right heart to be reduced. However, there 
is a reduction in the volume of the lungs during expiration 
and the flow to the left atrium is augmented, causing the 
left ventricular output to increase, The phenomenon de­
scribed above led Birtwell et s2. (17) to state that the 
major contribution of the intrathoracic pressure was upon 
venous return to the right heart. This explains the less-
than-optimum performance of an artificial ventricle under 
the adverse conditions imposed by an open-chest experiment. 
There has been a variety of animals used in artificial 
heart experiments. Dogs have probably been the most popular 
species mainly because of their availability, cardiovascular 
anatomy, and ease of handling. One of the more serious 
complications in the dog has been the occurrence of throm­
bosis and emboli. It is possible that this complication is 
less of a problem in man, since it has been proved that man 
can live with heart valves of a type that will invariably 
lead to thromboembolic death in a dog (66), 
Por long-term trials, fewer complications have been 
reported by using other species. Por total replacement of 
the natural heart with an artificial heart, the calf has 
been an effectual experimental animal (5). The use of the 
calf not only closely simulates human conditions (providing 
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that the calf's intra- and estracardiac fetal shunts are 
absent and that the bronchial artery blood flow is minimal) 
but also avoids the problem of blood clotting found in the 
dog (94). 
Sheep have some distinct advantages over both dogs and 
calves. The heart in large sheep approaches the size of a 
human heart, the tidal volume of the lungs in sheep and man 
is very similar, and the thromboembolic phenomenon experi­
enced with dogs is not as much of a problem with sheep (21). 
Mors important, the pulmonary shunting of blood that has 
been experienced in calves is not known to occur in mature 
sheep. Also J since the red blood cells of sheep are more 
fragile than those of mana dogs, or calves, sheep provide a 
more accurate index of the hemolytic potentials of the ex­
perimental procedures and devices (106). 
When calves were used as the experimental animal for 
heart replacement, pulmonary hypertension and poor oxygena­
tion frequently occurred as soon as the artificial heart 
began to pump blood (6, 117). The loss of oxygenation 
usually followed the development of an increased pulmonary 
arterial pressure. After prolonged extracorporeal circula­
tion in dogs and to a lesser extent in man indication of 
similar impairment in pulmonary function is well known (5). 
Akutsu et (6) surmised several possible causes for this 
pulmonary damage. They weno on to shovm that a sudden large 
flow into the pulmonary circulation after there had been 
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occlusion for a certain period of time produced the in­
sufficient oxygenation sydrone, ïhej recommended a gradual 
transition from the pump-oxygenator to the artificial heart 
as dictated by the oxygenation saturation of the pulmonary 
venous blood. However» in a later set of calf experiments, 
the group reversed this recommendation and adopted a proce­
dure in which the pump-oxygenator was stopped before the 
artificial heart started pumping ($4). This abrupt change 
over did not affect pulmonary function. A sure reason for 
this event was not given. 
Pulmonary complications may also develop if 1) pulmo­
nary venous hypertension is allowed to occur during perfusion 
of the entire body (117) or 2) the output of the right 
artificial ventricle exceeds that of the left (94). This 
latter situation is analogous to left ventricular heart 
failure in the natural heart. 
Experimental animals undergo quite a serious biologic 
shook in heart bypass and replacement trials. Thus criteria 
for survival need to be established. The indicators of the 
preservation of vital function might include femoral arterial 
V pressure values, pupillary and deep tendon reflexes, re­
cuperation of spontaneous respiration, and E3G findings 
(9, 79). Also for trouble-free pumping there must be mini­
mum destruction of blood elements, no pulmonary edema, and 
no serious thrombi formation. The above criteria are by 
no means exhaustive but they include the more important 
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indicators of life. For a closed-chest heart replacement 
experiment, the really only acceptable test of success is 
the awakening of the animal even if for only a short period 
of time. 
To conclude this section, a listing of the various 
causes of death in artificial heart experiments will be 
given. Disappearance of most of the reflezes and sustained 
detrimental values of the measured parameters are usually 
considered as signs of approaching death. The most frequent 
causes of death are as follows: 
1. Pulmonary edema (9» 57, 121) 
2. Clotting (9, 110, 121) 
3. Bleeding in chest cavity (2, 79) 
4. Pulmonary hemorrhage and cerebral damage (9) 
5. Air emboli and hypovolemic shook (121) 
6. Hepatic engorgement due to high venous pressure 
(57) 
7. Metabolic acidosis (110) 
The chart reproduced in Figure 11 is representative of 
the causes of death which have occurred with artificial 
hearts. It lists how various procedures can cause events 
to occur which ultimately result in the death of the ezperi- * 
mental animal. Finally it should be obvious that many 
artificial heart experiments have been terminated due to 
mechanical breakdown of the artificial heart itself, the 
external machinery, or the monitoring system. 
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Cardiac Work 
A study of cardiac work is important both in heart 
replacement and heart assistance studies since it gives an 
idea of the expected energy demand to be placed on the 
artificial blood pump. Por instance, it has been deter­
mined that a pump with an efficiency of 25 percent when 
supplied with 3.17 watts of mechanical power could circu­
late 5570 milliliters of blood per minute against a pres­
sure of 100 millimeters of mercury (109). 
Since the left ventricle expends the majority of the 
effort needed to propel blood through the cardiovascular 
system, most formulae for cardiac work are applied to the 
functioning of the left ventricle. The left ventricular 
work can be calculated from the formula (102) 
W = ?Y ( 1/2) (w/g) v^ 
where ¥ = cardiac work in kilogram-meters 
? = mean aortic pressure in meters of blood 
V = minute volume in liters 
w = weight of blood in kilograms 
g = acceleration due to gravity in meters per second 
v^ = square of mean blood velocity in meters^ per 
2 
second 
The kinetic energy component represented by the second term 
of the formula is about five percent of the total work under 
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ordinary resting conditions (73). This latter term along 
vith the work associated with the coronary blood flow is 
usually disregarded 'in the calculations. 
In a practical sense, left ventricular minute work can 
be calculated as the product of left ventricular output 
in liters per minute divided by 100 and the mean systolic 
pressure in centimeters of water (76). Other formulae are 
evident in the literature but they differ mainly in the 
units used to measure the pressure (18, 73, 120). However, 
these formulae fail to show that the product of flow rate 
divided by 100 and the pressure does not lead directly to 
work in kilogram-meters per minute. ?or the above formula 
the conversion is 
(1 liter) (1 centimeter of water) _ -o—^ ki1ogram-meters 
(minute) [100) ' minute 
For a normal heart it has been found that the mechanical 
I 
energy necessary to propel the blood of a resting human is 
about 0,25 gram-calories per minute (13). This is equiva­
lent to 0.106 kilogram-meters per minute and includes the 
work of both ventricles. 
Another practical way of determining cardiac work is 
by measuring the oxygen uptake of the cardiac muscle itself. 
This is closely associated with a parameter called the time-
tension indez (37). This index is the product of the pres­
sure gradient against which the left ventricle must eject 
61 
blood into the aorta and the duration of that ejection. 
Sarnoff ^  (104) clarified that this index was the chief 
determinant of heart work, as measured "oj the oxygen con- • 
sumption. One group applied the time-tension index to 
the design of their auxiliary ventricle in an attempt to 
reduce left ventricular %^rk (of the natural heart) by 40 
to 50 percent (50). 
Pot-rer Systems 
The overall success of an artificial heart is highly 
dependent on the type of energy conversion system which is 
selected to po^'er such a mechanism. At the present time 
any artificial heart that is enclosed in the chest remains 
dependent on a permanent power supply from outside the 
body. Power transmission through the chest wall by means 
of wires (electrically) or tubings (liquid or gas under 
pulsating pressure) appears to be the most feasible method. 
Figure 12 demonstrates some of these possibilities. 
The use of electricity is extremely inviting. Elec­
trical energy is readily available, easily stored, and can 
be reliably controlled. In spite of these advantages, 
there are several problems inherent with the present elec­
trical energy conversion systems which include excessive 
heat production, low efficiencies, and mechanical failure. 
Three devices knoifn for electromechanical means to 
drive an artificial heart are solenoids, electromotors. 
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and piezoelectric crystals. 
The first artificial heart built by Kolff was driven 
"by five small solenoids (65). An electromagnetic solenoid 
is an attractive prime mover for a prosthetic heart because 
it is sisple and may he located outside the body as an air 
pump or incorporated in an artificial heart implanted in 
the chest. 
•There are three classes of solenoids that may be con­
sidered for energizing an artificial heart: d-c powered, 
a-c poT-jeredj, and pulse povrered (14). Kolff (64) discusses 
the fact that pulsing solenoids makes it possible to reduce 
their vreight by 75 percent and yet have the same pumping 
capacity as d-c powered ones. Bindels (I5) calculated 
values of efficiency of solenoids delivering the mechanical 
energy necessary to drive artificial hearts which were 
capable of supplying only basal flow rates and pressures. 
?or a prohibitively large solenoid he found an efficiency 
figure of 98 percent. 
Most motor-powered artificial hearts have been of two 
types. In one type, the motor, through a system of gears, 
pivots, and eccentrics, swings back and forth within a 
rigid housing (60). As it is driven back and forth, the 
body of the motor alternately compresses each ventricle 
against the housing and expells the ventricle's contents. 
In the second type of notorized artificial heart, the motor 
is fixed and a driven member performs the work (3, 100, 101). 
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The driven member can be a freely moving roller which al­
ternately compresses either a set of ventricles or a single 
section of tubing, The other possibility for a driven 
member is a piston (24, 28, 62, 97, 99). Burns et al, (27) 
described a heart in which the built-in motor provided 
power (pressure head) to a hydraulic fluid which, in turn, 
was controlled by a built-in valve. The movement of the 
fluid caused the compression of the ventricles* 
Various power requirements for motorized hearts pumping 
at physiologic flow rates and pressures have been reported, 
low power levels of 15 watts and ^0 watts have been attained, 
with the lowest reported value to be 7.5 watts (99, 100, 
101). 
The third mechanism utilizing electrical power is a 
piezoelectric artificial heart, A piezoelectric material 
changes shape on electrical stimulation and thus, in some 
respects3 behaves as muscle tissue. The use of a material 
of this type permits a direct and efficient conversion of 
electrical energy to pumping energy. loehr et a^. (80) 
developed a piezoelectric device which pumped a working 
fluid of low density and viscosity back and forth to an 
artificial heart. Their crystals exhibited an excellent 
response to a variety of voltage excitation patterns. The 
units generated no heat and the conversion of electrical to 
mechanical energy was found to be nearly 100 percent. 
The use of air eliminates problems of weight, size. 
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shape, heat production, and insufficient power, since air-
driven hearts are smaller, lighter, more reliable, and 
easier to insert in the chest than artificial hearts that 
use motors or magnets (110). In this regard, the advan­
tages of air-driven hearts are many, iiir is a fairly 
efficient '-zorlcing fluid at the loT-r pressures required and 
there is little energy loss from compression (45). Another 
advantage of an air-driven system is that more components 
of the system can be located outside the body, thus easing 
maintenance and repair. Operation of a pneumatic system 
with carbon dioxide provides added safety in case a leak 
should develop in a diaphragm of this type of heart since 
carbon dioxide dissolves in blood much faster than does air. 
There are two types of air-driven power systems both 
of which require a tube into the chest cavity (75). In 
the "closed system" a rolling diaphragm pump, driven by a 
small motor, pumps air in alternate directions. There are 
other methods to produce the alternating air flow but the 
common factor to these systems is that the mass of working 
substance remains constant. The "closed system", if air 
is used, does not tend to produce excessive elevation in 
arterial pressure, since the systolic stroke is regulated 
by the actual arterial pressure. 
In the "open system" power is derived from a compressed 
air line, oxygen tank, or a similar source. The systolic • 
and diastolic times are regulated by electric or pneumatic 
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valves. This system works under high pressure and is so 
named because, during dizstole the volume of air used 
during systole escapes from the pump. The "open system" 
requires constant regulation. 
Hydraulic systems of the "closed" type have also been 
employed to drive artificial hearts (57, 80). Again a 
tube into the chest cavity is necessary. 
It would be advantageous from the standpoint of avoiding 
infection to have no power connection (wires or air lines) 
through the chest wall. Zusserow (63) described a method 
in which a motor-driven permanent magnet on the outside of 
a tissue barrier drove a slave magnet within. 
The most potentially attractive system for supplying 
energy to an artificial heart involves inductive coupling 
'between a flat pancake-shaped coil on the surface of the 
chest and another similar coil within the chest. Schuder 
et al. (108, 109) demonstrated that such an arrangement 
could transport 50 watts through the chest wall with no 
apparent discomfort to the animal and without appreciable 
temperature rise in the coils or tissue. They further stated 
that this energy could be transported with losses in the 
coupling coils and tissue of approximately five percent of , 
the transported power. The 50 watt figure given above is 
approximately 150 percent of the calculated power input to 
the biological heart of an adult under conditions of exer­
cise (109). In seeking methods for improving the transport 
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efficiency, Schuder and Stephenson (107) also investigated 
the possibility of utilizing magnetic material, ferrites 
in particular, for the core of the receiving coil. 
Biopsies from the tissues of dogs exposed on a chronic 
basis to an electromagnetic field equivalent to that re­
quired to transport 50 i-ratts through the chest i-Jall have 
been negative at two and three years (58). furthermore, 
studies on heat dissipation in dogs have indicated that 
from one-fourth to one-half calorie per kilogram per second 
can be dissipated into the blood stream without ill effects 
( 2 5 ) .  
Totally implantable nuclear power sources are also 
conceivable (26). If perfected, they would permit a 
complete and long-term replacement of a normal heart with 
no dependence on external energy sources. 
The possibility of utilizing a relatively large 
skeletal muscle mass to power a small blood pump directly 
and continuously over extended periods of time has not 
been overlooked. Kusserow and Clapp (69) described such a 
method using the canine quadriceps femoris.,.-..They. found 
that cellular injury took place under the conditions of the 
experiment, despite the satisfactory kinetic performance of 
the muscle throughout the period of stimulation. Another 
disadvantage of this method is that it necessitates wires 
passing through the chest wall to stimulate the muscle mass. 
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Control Systems 
îîis objectives of most research groups concerned vith 
artificial heart development encompass three design prob­
lems: 1) the artificial heart itself; 2) an efficient 
and suitable power source; and 3) & system for the control 
of the output of the artificial heart in response to chang­
ing needs of the experimental subject. Artificial ventri­
cle systems have been designed which reasonably duplicate 
the flow and pressure waveforms cf the natural intact 
heart (89, 111). However, the development of an automatic 
control mechanism for these artificial pumps is a different 
and more difficult type of design problem. 
The normal heart is controlled through nervous and 
humoral channels which are responsive to many body functions 
and actions. When an artificial heart replaces the normal 
functioning heart, the problem of control becomes exceed­
ingly important. Almost any air-driven artificial heart 
of the diaphragm type that does not have a fixed stroke 
volume will, on its oi-m, follow Starling's law to some 
extent (114). (The consequence of this law is that the 
amount of blood pumped is proportional to the degree of 
diastolic filling). For adequate performance, however, more 
sophisticated control is absolutely necessary. The control 
system must be concerned with the transduction of appro­
priate physiologic signals, processing these signals and 
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making decisions based upon them, and finally actuating the 
artificial device. These actions should be done with mini­
mum demand upon voluntary controls and artificial energy 
sources. 
It has been said that "it is a combination of complex­
ity and ignorance (or uncertainty) that forces one to employ 
feedback control" (11). If the operating characteristics 
of the circulatory system were fully understood, the system's 
responses to ezeroise? drugs, and stimuli would be known. 
Then on the basis of this knowledge the behavior of the 
system could be predicted well in advance and the proper 
action to take to hold a control parameter in line with a 
desired level could be computed. 
Unfortunately the literature describing the automatic 
control of artificial hearts is not abundant. The reason 
for this may be that the duplication of the primary func­
tion of the normal heart (to pump blood) was envisioned to 
be a much easier task than the duplication of the complex 
and accurate regulation of its action. 
The first control systems, and many, now in trial use, 
depended on an easily obtained method of control — human 
attendants. By observing several physiologic parameters, 
a human operator (or sometimes an entire team) could easily 
adjust the operating point of an artificial heart. This 
means of control, however, is a waste of both money and 
human talent. 
69 
îhe main function of the heart is to provide an ade­
quate cardiac output. Since cardiac output is the product 
of heart rate (in beats per minute) and stroke volume (in 
liters per beat), there are two means of effecting control 
of heart output. With, air-driven artificial hearts chang­
ing the stroke volume seems to be the most popular method. 
With motor-driven artificial hearts changing the cycle 
rate predominates. 
She Cleveland Clinic group has published ti-ro articles 
describing design criteria for artificial heart control 
systems (58, 39). iJose (89) stated that for optimum per­
formance, the control of right and left artificial ventricles 
should' be separate and independent. This criterion is not 
universally accepted. In any event the control system 
must at all times provide sufficient blood flow to avoid 
tissue ischemia. The blood flow rates of each ventricle 
should be balanced. However, it is not necessary to have 
this equality hold on a beat-to-beat basis. It is probably 
adequate to base the flow equality on a few minutes timing 
(94). I'laintenance of flow balance avoids pooling of blood 
both in the pulmonary circuit and in the systemic circuit 
and prevents air emboli and the disruption of pump-to-vessel 
connections. The use of atrial blood pressure as a control 
parameter provides some degree of flow balance. This will 
be described later. 
There have been several notable means of external 
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control developed to regulate an artificial heart. However, 
the greatest effort has "been expended in designing self-
regulating artificial hearts, since self-regulation consti­
tutes a very desirable means of control. 
The role that atrial pressure has in the regulation 
of the normal heart was described earlier (Starling's law). 
2?ct all development groups considered this law, to be of 
much importance in their control systems. Howeverj the 
majority of the artificial heart developers did at least 
recognize the necessity of atrial pressure regulation and 
many utilised it in their control systems. Eose (89) 
stated that the feedback system that controlled the arti­
ficial device should be sensitive to the venous pressure 
and that this input pressure should be kept within a desired 
range. He further stated that this mechanism itself was 
sufficient. Venous pressure regulation of an artificial 
ventricle's fluid output prevents both abnormally high and 
low venous pressures from occurring and thus inhibits the 
venous system from experiencing overdistension and collapse. 
The efficacy of atrial pressure regulation is probably 
best summed up by Dr. Jesse Meredith (32) when he commented 
on the work done by Pierce ^  (97): "If one assumes that 
under standard conditions the heart is a constant flow pump 
or a constant current generator and that it is controlled 
by pressure to produce a constant flow under a given set of 
standard conditions, also if one considers that under normal 
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conditions the venous return is a good measure of the blood 
flow, and if one agrees that central venous pressures are 
proportionate to venous return, then the device described 
by Pierce is a device which tends by negative feedback to 
produce a constant cardiac output. By this concept it has 
an important virtue in development of replacements for the 
heart." 
An added benefit of having ventricular output con­
trolled by atrial pressure is that it automatically leads 
to an adjustment of the amount of blood pumped by each side 
of the heart (66), Plow equality occurs since a deficiency 
on one side inevitably leads to an increase in venous pres­
sure on that side which, in turn, increases the cardiac 
output on that side. 
Norton, Akutsu, and Kolff (88), Atsumi et a^. (9), 
Hastings et al. (56, 57), and Burns et (26) have based 
the construction of their hearts and ..control, systems- upon 
the hypothesis that cardiac output should be controlled by 
venous or atrial pressure. Â'ose _et (94) controlled 
their air-dfiyen pumps by changing the air pressure to the 
individual ventricles. They attempted to maintain right 
and left atrial pressures within a range of 10.0 to 15.0 
centimeters of water (7.36 to 11.03 mm. Eg). Kolff et al. 
(66) found that, by using a U.A.S.A. servomechanism, there 
was an instantaneous response in change of output from one 
side of the circulation to the other. They stated that this 
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action was the strongest argument they knew of to predict 
the success of a regulating mechanism in which the atrial 
pressure determined the cardiac output of the ventricle. 
Seidel _et a^. (110) developed an artificial ventricle 
which permitted an increased diastolic filling and hence 
an increased stroke volume proportional to a rising venous, 
pressure. They regulated the driving air pressure so that 
the blood chamber just emptied within a given systolic 
time. As long as the chamber completely emptied during 
systole, the artificial ventricle used venous pressure for 
the automatic adjustment of its output. 
Pierce et (97, 98) and Burney £t (24) have 
designed a control system based on continuous regulation of 
venous pressure. Their system used two integral diaphragm 
pumps of the piston type which were driven by small d-c 
motors. Thus each pump required only a source of electri­
cal power. The motor speed and hence the pump's fluid 
output changed as a function of the integral of the venous 
inflow pressure. A problem with this system was that rapid 
and undesirable fluctuations in pump speed were caused by 
pressure transients in the inflow line. Mechanical damping 
of the pressure catheter eliminated this. 
The control system described in this dissertation 
follows the above idea except that continuous correction is 
not provided. Also the system is designed to regulate a 
pulsating pneumatically-powered artificial ventricle. 
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Recently Nose _et (90) described a very sophisticated 
control system which duplicated the Starling regulation of 
the normal heart. They found that the normal right ven­
tricular curve (fluid output versus filling pressure) had 
a slope of 4,3 liters per minute per millimeter of mercury 
at the operating point. Using a closed-loop computerized 
control system they were able to duplicate this sensitivity 
in vivo with an artificial heart. The command signal to 
the pressure servomechanism was modulated by the average 
atrial pressure in such a way that an increase in atrial 
pressure proportionally increased the strength of contrac­
tion of the artificial heart. 
Edwards and Bosher (40) described an automatic control 
system based on both arterial and venous pressure regulation. 
'Their argument was that these pressures are the only vari­
ables which instantaneously reflect changes in blood flow 
and thus they should govern the arterial delivery rate. 
(Their argument is possibly true since some measurable 
indices of body chemistry change only after the blood has 
passed through the patient's tissues for metabolic exchange). 
Their system exhibited a seven to eight second lag between 
the time a correction was made and the time when the change 
was noticed in the circulatory system. The delay in feed­
back caused the system to oscillate. Oscillation is also 
a problem with other control systems (55, 41, 97). In-
cidently the Edwards and Bosher control system was capable 
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of changing the cardiac output at a maximum rate of two 
liters per minute per second. 
A major obstacle in automatic control is that of in­
adequate blood return from the animal's circulation to the 
artificial ventricle, liotta e_t (79) concentrated their 
efforts on regulating the end-diastolic volume of their 
artificial heart so as to 1) maintain a systolic residue 
of one-third of the stroke volume to avoid excess trauma 
to the blood, 2) maintain filling pressures of 10.0 to 
15.0 centimeters of water without provoking negative pres­
sure in the atria, and 5) provide maximum filling' time. 
Since the natural heart serves-as a recipient of many 
signals from the body it is obviously an important element 
in normal c'ontrol. If the pacemaker of the natural heart 
were to be left intact and functional, it could be utilized 
to pace an artificial heart (54). This would allow for 
at least partial biologic control of cardiac output. This 
method of biologic control has been utilized but not without 
some problems. Liotta (73) found that attaining an 
acceptable degree of reliability was a dilemma. Motion 
artifacts and noise were problems. However, the placement 
of electrodes appeared to be relatively unimportant and 
ventricular fibrillation never occurred. 
Many of the artificial hearts developed had a high 
degree of intrinsic control and needed no sophisticated 
external control system. An intrinsically-controlled 
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ventricle must obey Starling's law as closely as possible. 
To do this, provision must be made to 1) allow the ventric­
ular volume to vary and 2) limit ventricular pressure during 
diastole. These requirements eliminate rigid mechanically-
coupled driving units and mechanically-powered hydraulic 
units. However, pneumatic units easily meet these require­
ments and also allow for easy incorporation of other desir­
able characteristics. Akers ejfe (l) developed a system 
based on the above criteria for a self-regulating device 
which contained both a specialized air pulse generator and 
a bypass pump. 
The fluid amplifier, a device for controlling the flow 
of fluids without moving parts, seems to be an appropriate 
intrinsic control mechanism for an artificial heart. Sev­
eral fluid amplifier-controlled artificial hearts have been 
built which demonstrated relatively stable control of atrial 
pressure (10, 33, 121). 
The operating principles of fluid amplifiers are 
excellently described in an article by Angrist (7). The 
advantages of an artificial heart controlled by a fluid 
amplifier are listed in Figure 13. It should be obvious 
that the fluid amplifier provides control flexibility not 
enjoyed by pneumatic control elements. 
Barila et al. (10) developed a plastic ventricle which 
was powered by compressed air and controlled by a fluid 
amplification system. The flow rate of the ventricle was 
76 
governed by the filling blood pressure, the resistance of 
the outflow tract, and the driving air pressure. The air 
pressure applied to the ventricle was regulated so that the 
minimal force necessary to just overcome the outflow re­
sistance was used. The pump responded automatically by 
an appropriate alteration of both stroke volume and pulse 
rate. The pump produced flow rates from 0.5 to 10.0 liters 
per minute at rates of 20 to 125 pulses per minute. When 
tested ^  vitro, the pump produced very little hemolysis, 
Oastaneda £t ( 3 3 )  developed the Army Artificial 
Heart, a fluid amplifier-controlled pump, whose operation 
was governed by four factors: 1) systolic air pressure; 
2) pulse duration; 3) pulse rate; and 4) ventricular suc­
tion. The fluid output varied directly with changes in 
filling pressure and inversely with output resistance. 
They also found that all the factors except systolic air 
pressure played relatively minor roles in determining the 
fluid output. 
Woodward ^  (121) designed an intrathoracic fluid 
amplifier-controlled artificial heart which maintained 
venous pressure properly when adequate venous return was 
present. Their intrinsic control system allowed the ven­
tricle to fill more rapidly when the venous pressure was 
high, and this increased the pulse rate. Conversely, low 
venous pressure caused the ventricle to fill more slowly 
and the pulse rate decreased. They also stated that high 
77 
venous pressures resulted in somewhat larger stroke volumes, 
but that pulse rate was the dominant means of flow regulation. 
Although it is thought by some that automatic control 
of an artificial heart is a relatively simple problem, no 
one can say that it is a minor field of investigation. With 
implant trials of long duration a very definite possibility 
it may very well be that additional serious post-implant 
problems will be observed in vascular tone, blood clotting, 
healing, and the matching of subject and machine control 
systems. These complications may be due to very subtle 
incongruities in the performance of the mechanical system 
with respect to the optimal performance of various body 
systems. Optimizing the response of the physical control 
system to those controls operating in the living subject 
will tend to minimize or eliminate any occurrence of irre­
versible circulatory embarrassment. The development of a 
miniaturized, implantable, self-regulating control system 
responsive to the body's own remaining signals is a fasci­
nating challenge to both medicine and engineering. 
Cardiac Assister Devices 
There is another area of prosthesis development which 
can be tied in with artificial hearts. This area is con­
cerned with mechanical devices to assist, not replace, the 
failing heart. Some research groups-would rather leave the 
diseased heart intact and replace or supplement only the 
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heart's function, thus enabling the heart to heal. These 
circulatory assistor devices must 1) reduce the ventricular 
diastolic pressure of the failing heart chamber or reduce 
the flow of the weakened ventricle, 2) provide sufficient 
blood flow to the body, and 3) not cause further damage to 
the heart or other vital structures. 
Methods of accomplishing prolonged heart assistance 
include; 1) counterpulsation or arterio-arterial pumping; 
2) diastolic augmentation; 3) left ventricular bypass; 4) 
synchronous respiration; and 5) automatic heart massage. 
No matter what method of assistance is used, it has 
been found that to relieve the load of the left ventricle 
the pump circuit has to carry at least 50^ of the cardiac 
output (36). Also it is difficult to carry out controlled 
evaluations of the efficiency of assistive techniques since 
the experimental animal cannot readily be placed into a 
standardized degree of cardiac failure for testing the 
beneficial effects of mechanical cardiac assistance. 
Counterpulsation aims at increasing coronary arterial 
perfusion by raising the pressure during diastole and de­
creasing the work load of the left ventricle by lowering 
the pressure during systole (18). The method is based on 
the concept that a competent aortic valve effectively iso­
lates the left ventricle from the increased diastolic 
perfusion pressure created by a synchronous pulsatile pump. 
Most of the machines have been designed to withdraw blood 
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from the arterial tree during systole with consequent re­
duction in systemic resistance and to return it during 
diastole, using a portion of the electrocardiogram as a 
triggering signal. Oallaghan et aj. (50) found that if 
myocardial work was to be lowered, not only must the sys­
tolic arterial pressure be reduced, but the end-diastolic 
pressure, which represents the static load on the heart, 
must also be reduced. Mantini _et (81) found that 
synchronized counterpulsation was a useful therapeutic 
remedy in experimental canine cardiogenic shock. 
There are several ways of accomplishing counterpul­
sation. Oallaghan e_t aJ. (30) described a computer-auto­
mated counterpulsation system which was connected to a 
femoral artery. A cardiac homotransplant with an insuffi­
cient aortic valve can be synchronized to function as an 
arterial counterpulsator. Gannon et aj. (46) demonstrated 
this novel method by suturing a donor heart to various 
portions of the thoracic or abdominal aorta in dogs. They 
obtained favorable results with a maximum survival time of 
14 days. 
Diastolic augmentation of pressure in the aorta, like 
counterpulsation, promotes coronary flow with no additional 
burden on the left ventricle. Diastolic augmentation dif­
fers from counterpulsation in that during heart systole the 
augmenter device remains passive and becomes active only 
during heart diastole. 
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Intrathoracic methods of diastolic augmentation will be 
discussed first. Only one biologic method has been at­
tempted — the use of a skeletal muscle to assist myocardial 
function. Kantrowitz (61) wrapped the autogenous left 
hemidiaphragm around the distal thoracic aorta and applied 
intermittent stimulation to cause muscle contraction in 
time with normal heart diastole. Liotta _et (76) also 
applied diastolic compression to the descending thoracic 
aorta, but used a five to eight centimeter length of pneu­
matic sleeving. Moulopoulos _et (87) developed an aug­
menting system which periodically inflated and deflated a 
long, narrow ballon inserted in the descending aorta. The 
balloon was inflated during diastole of the natural heart's 
cycle and increased the diastolic blood flow to the periph­
ery. 
îîose _et (93) developed what they named an auxiliary 
ventricle. This pneumatically-operated, rubberized, col­
lapsible bulb was implanted end-to-side in the ascending 
and descending aorta, thus bypassing the aortic arch. The 
valveless unit filled passively during normal heart systole 
and then during diastole it expelled its blood back into 
the aorta. In later papers in which the same pump was used, 
the ascending aorta was ligated above the unit to increase 
blood flow in the auxiliary ventricle and thus diminish the 
risk of clotting (50, 91). Birtifell ^  (16) developed 
an externally actuated, subcutaneous "in-series" prosthetic 
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left ventricle. The ventricle was energized by applying an 
external pneumatic actuator to the device. Infection prob­
lems were reduced considerably since the skin barrier was 
intact. 
The most notable method of extrathoracic diastolic 
augmentation is that of external compression of the lower 
extremities. External compression is an effective approach 
for assisting the circulation for long periods since the 
requirements of cannulation, anticoagulants, and anesthesia 
are eliminated. Dennis ^  (37) found that, in the dog, 
the arterial blood expressible was of the order of magnitude 
of three milliliters per kilogram of body weight. In a study 
by Birtwell _et aJ. (15) the data indicated that venous return 
and aortic pressures could be modified effectively so as to 
reduce left ventricular work and, at the same time, increase 
cardiac output. 
The "in-series" auxiliary ventricles mentioned above 
aid the heart by reducing the pressure work of the heart. 
This is in contrast to ventricular bypass devices (or 
"shunt" auxiliary ventricles) which aid the heart by reducing 
the flow work of the heart. Much effort has been concen­
trated on left ventricular bypass devices and procedures 
due to the relatively higher occurrence of left ventricular 
failure over that of right ventricular failure. 
The air-driven, tube-type pump developed by liotta 
et al. (73) performed successfully in 47 left ventricular 
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"bypass procedures in dogs. The pump functioned up to 44 
hours in one case. This group's pump and their later ones 
(76, 77, 78) were in the form of small U-shaped tubes and • 
were connected between the left atrium and the descending 
aorta. Birtwell et al. (16) developed a similar pneumat-
ioally-powered device for use as a left ventricular shunt. 
Akers _et ( 1 ) and Hall _et (53) described a para-
corporeal bypass pump powered by air pressure. The bulk 
of this pump was on the outside of the body. Two tubes 
led into the chest cavity for connection to the left atrium 
and to the aorta. The use of two artificial ventricles in 
a double ventricular bypass procedure has also been reported 
(75). 
Roughly in the same area of ventricular bypass devices 
was an intraventricular artificial heart described by Hall 
et al. (54, 55). They developed silicone rubber pumps which 
were placed inside the contours of the right and left ven­
tricles. The sac-type pumps incorporated atrioventricular 
valves and utilized the existing aortic and pulmonary valves. 
Sight heart assistance by synchronous respiration is 
based on the hypothesis that the lungs can be made to exert 
an optimal pumping effect if the size of the pulmonary vas­
cular bed can be increased at low alveolar pressures during 
right heart systole, and decreased by a higher alveolar 
pressure during diastole (113). Naturally this type of 
assistance has a large influence on the pulmonary circulation. 
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Birtvrell ^  (17) found that the venous return to 
the right heart responded quickly to synchronous changes' in 
intrathoracic pressure. Soroff _et (113) studied the 
effect of synchronizing the inflation and deflation of the 
lungs with different portions of the cardiac cycle. They 
found that, with proper phasing, the pressure which must 
be exerted by the right ventricle was diminished. 
The last method of cardiac assistance to be discussed 
is that concerned with heart massagers. In this method, 
the cardiovascular system remains intact. This eliminates 
both a very large operative procedure and total body hepa-
rinization for prolonged periods. Also the normal endo­
cardium, as well as the normal cardiac valves, are func­
tionally retained. The heart muscle exerts force by con­
tracting and shortening, both of which are simulated by the 
massage devices. A final advantage of this type of cardiac 
support is that it can be used with either a fibrillating 
or a failing heart. 
Zajtchuk et (124) developed a heart-shaped plastic 
enclosure into which the heart was slipped. Pulsating air 
pressure provided the energy to massage the heart. Upon 
histological examination of the heart, liver, lungs, kidney, 
and blood elements no tissue damage could be demonstrated 
at the time of sacrifice of the experimental animals. 
Anstadt _et al. (8) described a pneumatic instrument 
which assisted the heart during both the systolic and 
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diastolic phases of the cardiac cycle. The force was applied 
exclusively to the walls of the ventricles with no inappro­
priate force applied to the atria. They obtained cardiac 
outputs from 70 to 100 percent of control values in dogs 
during ventricular fibrillation and had survivals often up 
to eight hours of total circulatory support. 
Both of the previously mentioned massagers caused the 
assisted heart to go into systole with the application of 
air pressure. The rubber massager developed by Kolobow 
and Boi-nnan (67) normally compressed the heart into its 
systolic form. Upon the application of suction, the device 
allowed the heart to go into its diastolic form. This 
device functionally simulated the contracting atria in 
addition to energizing both ventricles. 
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THE ASTIPIGIAL VEilTRICIS SYSTEM 
The Artificial Ventricles 
Three pneumatically-powered artificial ventricles 
were developed in the course of this study. All of the 
models were oversized prototypes designed mainly for the 
evaluation of the power and control system during extra­
corporeal use. I'one of the models were designed for intra­
thoracic implantation. Also, the artificial ventricles 
were used only in short-term trials during which the natural 
heart of an experimental animal was bypassed but left in 
place. All of the ventricles (except Model I) operated 
in a position adjacent to and outside of the chest. Con­
nections were made to the animals' great vessels by short 
polyvinyl chloride catheters. 
The design, fabrication, and testing of only artifi­
cial ventricles were originally undertaken. The hope was 
to utilize the intact atria of a deventricularized heart 
to serve as filling and pressure-buffer chambers for the 
artificial ventricles. However, since none of the ventricles 
were implanted within the chest and only heart-bypass exper­
iments were conducted, the fabrication of artificial atria 
was necessary. These small, collapsible chambers not only 
facilitated ventricular filling but also absorbed the nega­
tive pressure impulses which occurred during the filling 
phase and which tended to collapse both the artificial 
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atria and the great veins. 
The basic construction and the operating principle of 
all three models are essentially identical and all are pow­
ered by short pulses of compressed air. All models employ 
small flap valves to insure unidirectional liquid flow and 
a thin stretchable diaphragm to transfer the pneumatic 
energy into liquid pumping energy. The liquid stroke volume 
is altered by changing the pressure of the air being pulsed 
to the ventricle. This is the means by which the automatic 
control system functions to regulate the ventricle's liquid 
output. 
The flap valves used in all three artificial ventricles 
are cut from thin (0.050 inch) medical-grade silicone rubber 
sheeting. The valves for the Model II ventricle are shown 
in Figure 14. There are two pieces to each valve unit — 
the flexing flap part (O) and the stationary seating part 
(D). The seating part is not necessary if a proper valve 
seat is constructed into each valve housing. However, the 
use of a seating part of like material does compensate for 
roughness and unevenness in the machined valve housings and 
provides an excellent seal to any backflow of liquid. 
The operation of. the flap valves is electrically anal­
ogous to the action of a diode. The valves operate entirely 
passively and offer little resistance to forward liquid flow 
while offering considerable resistance to reverse liquid 
flow. 
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These valves would not be considered adequate for long-
term use since there is a substantial amount of flexing along 
the hinge line. Also with repeated use, the flap part of the 
valve has shown some tendency to take on a permanent "set" in 
a partially opened position, thus requiring greater backflow 
of liquid to close the valve. Redesign of the valve or the 
substitution of a better material would help to solve this 
problem. Ease of construction and maintenance and small dis­
placement volume were distinct advantages of these valves. 
The flap valves were used throughout the project since 
appreciably better valves of other types were neither readily 
available nor adaptable. 
As was mentioned previously, all three artificial ven­
tricles follow the same principle of operation. The method 
of operation will be described with reference to Figure 15 
which is a cross-section view of the Model II artificial ven­
tricle. A flexible diaphragm divides the ventricle into two 
compartments, a liquid chamber and an air chamber. When a 
volume of compressed air is pulsed into the air chamber, the 
diaphragm bulges upward into the blood chamber (emptying 
phase). This action closes.the inlet flap valve and displaces 
a volume of liquid through the flap valve in the outlet port. 
During the filling phase the compressed air is vented to the 
surrounding atmosphere, thus allowing the diaphragm to recoil 
to a rest position (or beyond). This action creates pressure 
gradients which close the outlet valve and open the inlet 
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valve, thus allowing the liquid chamber to be refilled 
through the inlet port. (The amount of refilling is a func­
tion of the input filling pressure, the inlet port diameter, 
the liquid volume available for filling, the elasticity and 
degree of stretch of the diaphragm, and the time allowed for 
the filling phase.) The ventricle is now ready for the next 
pulse of compressed air and the cycle repeats itself. A 
continued series of air pulses, then, causes a periodic 
liquid pumping action to take place. 
The three artificial ventricles are shown in Figure 16. 
Model I was used only to ascertain the feasibility of the 
pumping method. It was not used in any animal experiments. 
The size, weight, and volumes of interest pertaining to 
this ventricle can be found in Table 1. Design specifica­
tions were made to conform to data of the functional per-' 
formance of the left ventricle of a 20 kilogram dog. 
The body of the Model I ventricle was made of plexiglass. 
The two chambers of the pump were held together with a ring 
of eight screws. The flexible diaphragm separating the 
air and blood chambers was cut from a section of thin (0.030 
inch) rubber drainage tubing. Connection to the air chamber 
was made by attaching an air hose to a brass adapter which 
was sealed into the air chamber. Two short lengths of 
polyvinyl chloride tubing (l/2 inch I.D. x II/16 inch O.L.) 
made up the inlet and outlet fluid lines. The tubes were 
bonded to the plexiglass valve housing with a silicone 
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rubber medical adhesive.^ The silicone rubber flap valves 
were attached inside the valve housing in a similar fashion. 
The purpose of the large adjustable air chamber in the 
Model I ventricle was to determine the optimum size for an 
air chamber. A large chamber tends to damp any fast pres­
sure rise introduced into the chamber. This absorption of 
pneumatic energy, then, lowers the peak pressure seen in 
the blood chamber and lengthens the rise time of the pressure 
pulse. The use of too small an air chamber can result in 
very rapid and detrimental pressure changes in the fluid 
output line. It was found, however, that an external air 
chamber in series with the air line functioned as an adequate 
damping mechanism. Thus as small an air chamber as possible 
was chosen for all subsequent models. This choice was ob­
viously advantageous from the standpoint of possible later 
intrathoracic implantation. 
?ollowing completion of tests on the-Model I-ventricle, 
a second prototype artificial ventricle was designed (Model 
II) and two units were constructed. These pumps were used 
extensively, in vitro tests and exclusively in both in 
vitro and 3^ vivo control studies. These ventricles were 
made of medical-grade silicone rubber and teflon. 
Medical-grade silicone rubber materials presently offer 
^Silastic ^  (Type A), Dow Corning Corporation, Medical 
Products Division, Midland, Michigan. 
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distinct advantages over other synthetic materials for use 
in artificial ventricles (22). They possess a low degree 
of biological reactivity. They are flexible and can be 
molded into practically any desired shape. A disadvantage 
is that they are somewhat friable. Also since they are good 
electrical insulators, it appears that the inability to 
dissipate surface electric charge might actuate the clotting 
mechanisms of normal blood (22). Advances in materials 
research, either in improved silicones or other new products, 
will most likely eliminate the disadvantages listed above. 
Teflon similarly possesses low reactivity in the inter­
nal environment of the animal body. Teflon construction 
has presented two major difficulties. Though it can be 
machined to a desired configuration, it is difficult to 
produce fluid-proof threaded connections. Secondly, its 
low degree of chemical reactivity makes it very difficult to 
bond teflon to itself or to other materials with adhesives 
or encapsulating materials. However, more reactive synthetic 
materials, when made blood-compatible by coating with heparin, 
offer distinct advantages in the design of blood-handling 
devices (49, 119). 
All of the parameters of the Model II ventricle except 
overall dimensions were designed to approximate the cardio­
vascular parameters of a 20 kilogram dog. The parameters 
pertaining to this ventricle can be found in Table 1. Each 
one-ventricle unit has been used in short-term right- and 
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left-ventricular bypass experiments to assess servomechanism 
control of "cardiac" output. The teflon unit has also been 
operated singly to evaluate other components in the entire 
system. In addition, a single unit has been found to perform 
as well as, if not better than, a commercial blood pump for 
extracorporeal circulation during total heart-lung bypass 
procedures. 
The disassembled teflon ventricle is seen in Figure 17 
and is shown diagrammatically in Figure 15. The identifying 
letters in the two figures correspond. The ventricle is 
basically a two-chambered cylinder (A). Two valve housings 
(3) each of which contains a one-way flap valve (C, 3D) are 
threaded into a cover (S). The cover is threaded into the 
cylinder. The depth to which the cover is inserted determines 
the volume of the artificial ventricle's liquid chamber. 
The cover is then usually sealed with a silicone rubber 
adhesive. The other section of the main cylinder is the air 
chamber. The thin (0.010 inch) diaphragm (?) is attached 
(with rubber cement) to a thin plexiglass ring (G). This 
member and another thin plexiglass retaining ring (H) are 
seated onto a ledge of the main cylinder and secured with a 
teflon threaded ring (I). Finally another cover (J) with 
its air hose connector (K) is threaded into the main cylin­
der. ilote that the volume of the ventricle's air chamber 
is also variable. The simplified construction of this 
ventricle made its maintenance and cleaning a simple task. 
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Pigure 17 also shows the accessory artificial atrial 
chamber (L) which is connected to the ventricle's fluid 
input port. This chamber buffers the pressure transients 
developed by the elastic recoil of the diaphragm during the 
filling phase. It is made of 0,020 inch dacron-reinforced 
silicone rubber. This chamber greatly aided the ventricular 
filling and therefore the pump's liquid output. Other arti­
ficial ventricle designers have reported the need for simi­
lar accessory chambers (92, 94, 121). 
Again, this teflon model was not designed for intra­
thoracic implantation. It was always operated in a position 
outside the chest and was connected to the great vessels 
by short, flexible plastic catheters (3/8 inch I.D. x 9/16 
inch O.D.). The ventricle proved to be quite acceptable 
for the experimental trials in which the intrathoracic 
placement of a pumping device was not required. 
Due to the small size of the liquid orifices in the 
Model II ventricle, abnormally high blood pressures occurred 
with attempts to obtain adequate blood flow rates in larger 
dogs. Thus a third extracorporeal model was fabricated. 
This model was designed not only with larger orifices but 
also to exhibit minimal stretching of the diaphragm at 
proper stroke volumes. Eo jji vivo control studies were 
conducted with this model and only a few vitro pumping 
tests were done on it. 
The main body, valve housings, thin rings, and covers 
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of the Model III ventricle were made of plexiglass. See 
Figure 16. Medical-grade silicone rubber, again, was used 
both for the one-way flap valves and the stretchable dia­
phragm. This was the only ventricle to be explicitly de­
fer a long pumping life. It has been suggested that if the 
amount of stretch in a piece of silicone rubber is less than 
ten percent of its original length, the dynamic life of the 
piece is greatly increased.^ This ventricle, then, was 
designed to have a liquid stroke volume of 0 to 100 milli­
liters with a corresponding linear stretch in the diaphragm 
of no more than ten percent. The parameters pertaining to 
the Model III ventricle can be found in Table 1. 
Although this artificial ventricle was designed as a 
substitute for the natural ventricle of a large dog (weight 
greater than 20 kilograms), it also found limited use in 
several heart-bypass experiments on sheep. In these exper­
iments the ventricle was quite inadequate due to 1) too thin 
a diaphragm (0.005 inch) and 2) improper extracorporeal 
placement of the device. Negative pressures resulting from 
large vein collapse caused the thin diaphragm to be pulled 
to the top of the liquid chamber thus severely affecting the 
filling process. Improved ventricular placement and a 
loholvin, Eeal R., Professor and Chairman, Biomedical 
Engineering Program, Iowa State University, Ames, Iowa. 
Seminar by Mr. Silas R. Braley, Director, Dow Corning Center 
for Aid to Medical Research, Midland, Michigan. Private 
communication, 1967. 
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thicker diaphragm would have helped but sheep trials were 
abandoned and no further tests were conducted on the Model 
III ventricle. 
One member (Oholvin) of the Iowa State University 
artificial heart group has designed an implantable two-
ventricle model which conforms to the shape of the natural 
heart. This model replaces only the animal's ventricles — 
the natural atria remain intact and are used for attachment 
and flow-buffering purposes. 
The performance of the artificial ventricle as a source 
of pressure and flow is dependent on many variables: 1) 
pulse rate; 2) percent systolic time (duty cycle); 3) pulsed 
air pressure; 4) positions of the air^bleeder valves; 5) 
output pressure head (load); and 6) input filling pressure. 
A family of curves showing how liquid output varies as a 
function of any of these variables could be dravra. However, 
probably the best way to depict the operation of the arti­
ficial ventricle is to show how liquid output varies with 
1) the output pressure head and 2) the input filling pres­
sure. Varying the pulsed air pressure in each test set-up, 
then, will generate a family of curves. The remaining 
variables must be kept constant. 
Following the ideas just described, liquid output tests 
were conducted on the Model II artificial ventricle. In 
each experiment water was used for the circulated fluid. The 
pressure conversion factor used was; 1.0 millimeter of 
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mercury (mm. Eg) = 1.30 centimeters of water. The other 
constants common to both tests v^ere; duty cycle — 53 l/3 
percent; rate — 70 beats per minute; and air-bleeder valves 
— closed. The same ventricle was used in each case. The 
results of these experiments are depicted in Figures 18 and 
19. It should be mentioned that these figures merely dem­
onstrate the ^  vitro capacity of the pump and lack the 
utility of jji vivo studies. 
Figure 18 clearly shows that, with constant input 
filling pressure, flow rate and output pressure head are 
inversely related at any given level of pulsed air pressure. 
Thus the ventricle is load sensitive. This is to be expected 
since the ventricle is not a fixed displacement pump. The 
maximum flow attained in this test was 2.6 liters per minute. 
Slightly higher flow rates are possible but the rubber dia­
phragm is prone to break if greatly overstressed. It should 
be mentioned that the output pressure head is analogous to 
the diastolic pressure level in the intact human circulatory 
system. 
The mo,del II ventricle failed to demonstrate any reli­
able degree of intrinsic regulation. That the fluid output 
was not a function of input filling pressure indicated that 
the ventricle did not follow Starling's law. This property 
is demonstrated in Figure 19 where the output pressure head 
was held constant while the input filling pressure was varied. 
The pulsed air pressure was also varied to obtain a family 
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of curves. The majority of the curves show relatively little 
variation in flow rate as the input filling pressure was 
varied fron -10.0 to +15.0 ma. Hg. These results were un­
expected since most diaphragm-type pumps that do not have a 
fixed stroke volume show some degree of self-regulation. 
Other artificial ventricles have been built which do show 
some intrinsic control by means of input filling pressure 
(3, 5, 56, 57, 60, 100). 
The lack of self-regulation was probably caused by 1) 
an unlimited filling volume available and 2) the rubber 
diaphragm being maximally stretched during each systole (for 
a given level of pulsed air pressure). During diastole the 
diaphragm recoiled to its rest position and created enough 
negative pressure to fill the liquid chamber to the same 
level each time. The Model II ventricle may be self-regu­
lating when used vivo, however, since 1) venous return 
volume is not unlimited and 2) during diastole the recoiling 
diaphragm often creates enough negative pressure to collapse 
the great veins, thus further limiting venous return. 
A distinction should be made between the distensible 
diaphragm ventricle (the type used in this study) and the 
rolling diaphragm ventricle. The latter type of diaphragm, 
being relatively inelastic, requires the application of a 
negative air pressure during the filling phase to assist in 
moving the diaphragm back to its pre-systolic position. The 
degree of diastolic filling, then, is dependent on both the 
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liquid input pressure and the level of negative air pressure 
applied (other factors being constant). Thus, if the level 
of negative air pressure was not too great (to cause venous 
collapse), a rolling diaphragm artificial ventricle would be 
expected to exhibit a dependency of stroke volume on the 
liquid input pressure. A rolling diaphragm ventricle which 
does show this dependency has been reported (88). 
A single hemolysis study was conducted on one of the 
Model II artificial ventricles using freshly drawn and 
heparinized canine blood. The degree of hemolysis, as meas­
ured by the amount of free plasma hemoglobin present in 
milligrams per 100 milliliters of whole blood, can be plotted 
as a function of time, the amount of blood pumped, or the 
number of passages of blood through the test circuit. Since 
these three variables are interrelated (see page 50), 'time 
was used as the independent variable. 
A graph of plasma hemoglobin determinations made at 
specific times over a continuous 75 minute period is shown in 
Figure 20. The ventricle pumped into a constant pressure 
head of 80 mm. Hg. The remaining pump adjustments were also 
held constant; rate — 70 beats per minute; duty cycle — 
33 1/3 percent; input filling pressure — 5.0 mm. Hg; and 
air bleed-off valves — closed. The initial priming volume 
was 800 milliliters and the blood flow rate was adjusted to 
tTrJo liters per minute. The graph shows that the destruction 
of red blood cells increased approximately linearly with 
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time, a phenomenon previously reported (118). 
The index of hemolysis (I.E.), as determined by the 
method of Wesolowski (118), was 0.1533 grams of hemoglobin 
released per 100 liters of whole blood pumped for the first 
30 minutes, 0.21? for the second 30 minutes, and 0.1748 for 
the overall 75 minute period. 'These values compare favorably 
with reported index of hemolysis ranges of 0.17 to 0.29 with 
canine blood (31, 101). Obviously, the silicone rubber flap 
valves caused some of the red blood cell destruction. Addi­
tional damage could have resulted from 1) a high blood flow 
velocity through the ventricle's output port, 2) incompati­
bility of blood with the components of the test circuit, and 
3) blood turbulence both in the return line and in the filling 
reservoir. 
The Pneumatic Power System 
An important aspect of artificial heart research is that 
of power transmission and conversion. Several sources of 
power are potentially useful for developing in an artificial 
device the power necessary to circulate blood. Among these 
are electric motors, hydraulic and pneumatic pumps, and 
nuclear devices. Other possible power systems include 
electromechanical converters utilizing electrical power trans­
fer through inductive coupling (107) and conversion of bio­
logical mechanical energy utilizing the piezoelectric effect 
(80). In both of these latter Instances there need be no 
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direct connections between the thoracic cavity and external 
body surfaces. 
Many research groups concerned with the problem of power 
have selected compressed gases to drive their artificial 
ventricles. Pneumatic methods are characterized by high 
transmission efficiency, relatively great energy storage 
capacity, easy controllability, availability, and portability 
(19). However, the type of power unit to be used is speci­
fied, to a large extent, by the desired operating character­
istics of the ventricle. 
The artificial ventricles used in this study'were 
powered by compressed air in an "open system" arrangement. 
The pneumatic power system was designed to be reliable and 
to adequately match the power requirements of all artificial 
ventricles developed in this study. It has proven itself 
to be sufficiently capable to perform these tasks. Basically 
the power system simply controls the movement of compressed 
air to and from the artificial ventricles. Oscillator-
driven electromagnetic solenoid valves function to control 
the rate and duration of the pulses of compressed air. The 
amount of air pulsed to a ventricle in each cycle is a 
function of 1) the pressure of the air source, 2) the amount 
of time the solenoid valve is open, 3) the degree of air 
bleed-off in parallel with the ventricle, and 4) the load 
imposed upon the ventricle by the animal's circulatory system. 
A block diagram of the pneumatic power system for one 
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ventricle is shovm in Figure 21. External to the actual 
power module are the source of compressed air, an "on-off" 
air valve, and the artificial ventricle. The pressure of the 
air entering the module (approximately 90 pounds per square 
inch) is indicated on a 0-100 pounds per square inch pres­
sure gauge (labeled LIîîS PRESSURE). • At the point where this 
gauge is connected, the air line branches to the remaining 
components of both the right and left pneumatic power sec­
tions. 
Since the remaining components of both sections are 
identical, a description of only one section will be given. 
The next component in the air path, is a pressure reducer 
and regulator valve (labeled ADJUST) which sets the air 
pressure distal to it. This working air pressure is indi­
cated on a 0-30 pounds per square inch.pressure gauge 
(labeled PRESSURE). The range in which the ventricles are 
normally operated is from four to 12 pounds per square inch. 
However, these relatively high pressures (207 to 620 mm. 
Hg) do not appear in the air chamber of the artificial ven­
tricle. 
îîext in this series is the three-way electromagnetic 
solenoid valve whose operation is governed by the rate, duty 
cycle (lyiSMV), and solenoid driver circuits. In its unener-
gized position, the solenoid valve blocks air pressure at 
point A and provides an open air path from B to C. In this 
position, the air in the ventricle is vented to the 
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surrounding atmosphere and the ventricle refills with liquid. 
When the solenoid valve is electrically energized, the 
exhaust port C is closed and there is an open air path from 
A to B,, With the solenoid valve in this position a pulse 
of pressurized air is sent along three paths — to the arti­
ficial ventricle and to the surrounding atmosphere by way . 
of two air bleed-off valves. These adjustable needle valves 
are labeled KkWAL and COUTEOL VAIVS in Figure 21. The 
MÎÎUAL valve provides a limited amount of fine control over 
the action of the COHTRÛL VALVE. 
In normal operation of the power unit the MkllUAL valve 
is usually closed and the ADJUST control is initially set 
to obtain an adequate operating point. Then the C02ITH0L 
VAIVS (actuated by the motor in the automatic control system) 
alters the ventricular air pressure around the initial set­
ting. This latter action is in part responsible for deter­
mining the liquid output of the artificial ventricle. 
A photograph of the front panel of the rack-mounted 
pressure control module is sho-ivn in Figure 22. In addition 
to housing the air pressure controls and gauges mentioned 
above, this module also contains the motors of the automatic 
control system and various lamps which indicate the status 
of the control motors. The air pressure output connectors 
to the artificial ventricles are at the bottom center of the 
panel. A Model II ventricle is seen attached to one of these 
connectors. 
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A photograph of the back of the pressure control module 
Is shown in Figure 23. The electromagnetic solenoids (la­
beled SOL), control motors (labeled MOTOR), and the auto­
matically-controlled needle valves (labeled COJJTSOL VALVE) 
are easily seen. The air pressure input to the module is 
through the long ribbed hose in the center of the chassis. 
Other interconnecting air lines are evident in the photograph. 
The terminal blocks on the right and left edges of the chassis 
are for electrical connections to the solenoids and control 
motors respectively. 
All of the electronic circuits associated with the 
power system utilize solid-state devices. The basic rate of 
each ventricle is determined by means of a relaxation oscil-
ator circuit employing a unijunction transistor (47). The 
rate can be varied from 15 to 240 pulses per minute. The 
wide range in pulse rate was chosen to encompass not only 
normal heart rates but also very fast and slow rates for in 
vitro testing purposes. 
The oscillator pulses are fed into a three-transistor 
monostable multivibrator iViSlïV) circuit (47). This circuit 
provides one output pulse for each pulse received at its 
input. The output pulse width is variable from 0.2 to 3.0 
seconds. Thus, the duty cycle (or percent "on" time) of the 
MSI-fV circuit's output pulses is variable from five to 75 
percent (at a rate of 15 pulses per minute) or from SO to 
100 percent (at a rate of 240 pulses per minute). At a 
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normal rate of 70 pulses per minute the duty cycle can be 
varied from 23 l/3 to 100 percent. Relatively long duty 
cycles permit the possibility of having a programmed pres­
sure wave applied to an artificial ventricle. 
Another circuit in the device can be switched into 
operation to take the place of the previously described rate 
and MSMV circuits. This is a variable frequency, variable 
ratio pulse generator circuit (47). The rate is variable 
from 20 to 200 pulses per minute and the duty cycle, at 
any pulse rate, is variable from 0 to 100 percent. Thus 
either one of the two parameters can be set and will remain 
constant as the other parameter is varied. This circuit, 
when switched into use, operates both solenoid valves 
simultaneously at the set rate and set duty cycle. This 
circuit is most useful when two ventricles are being driven. 
The output pulses of either the above circuit or the 
FiSW'I circui't are fed to a solenoid driver circuit which 
utilizes a silicon controlled rectifier. The solenoid, then, 
meters the compressed air to and from the artificial ven­
tricle as described earlier. Other than the potentiometers 
and switches, the solenoid valves (one per ventricle) are 
the only components of the power system which are subject to 
mechanical wear. 
The power system is extremely versatile in that two 
artificial ventricles can operate either in unison (with or 
without identical duty cycles) or asynchronously at the same 
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or at different rates (again with, or without identical duty 
cycles). Pushbuttons are provided both for manual operation 
of each ventricle individually or together and for the in­
dependent stopping of each ventricle if necessary. Visual 
and aural indications are given for each "beat" of each 
ventricle and meter indications are provided for quick deter­
mination of both rate and duty cycle. Provision has also 
been made for accepting an external rate signal, for example, 
the atrial electromyogram of a deventricularized heart or the 
limb electrocardiogram of an animal with a bypassed normal 
heart. These electrical rate signals constitute other pos­
sible means of artificial ventricle regulation by feedback 
control. Figure 24 is a photograph of the module which 
contains the rate and duty cycle circuits, switches, and 
indicators along with several electronic power supplies for 
other modules of the overall system. 
There are four parameters which can be adjusted to alter 
the liquid output of the artificial ventricle: 1) the pres­
sure of the pulses of compressed air; 2) the duty cycle 
(fraction of entire cycle during which air enters the ven­
tricle); 3) the air bleed-off rate in the pulsed air line; 
and 4) the pulse frequency. In this study automatic ad­
justment of the third parameter regulated the stroke volume 
in response to an animal's changing circulatory needs. When 
the entire system was first put into operation, the rate, 
duty cycle, and working air pressure of the ventricle were 
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adjusted to give a satisfactory "blood pressure and flow rate. 
These adjustments, then, usually remained fixed. Then the 
control system took over the function of keeping the "blood 
pressure in the input line of the artificial ventricle within 
a predetermined reference zone. 
An actual air pressure waveshape taken at the "base of a 
Model II ventricle during a right ventricular bypass experi­
ment on a dog is shown in Channel 6 of the recording repro­
duced in Figure 25. This waveform was measured by means of 
a strain gauge pressure transducer ^ connected to the air 
chamber of the ventricle by a short air-filled cannula. 
There is some distortion to the air pressure tracing since 
the pressure-proportional electrical signal was capacitively 
coupled to the recorder. The resulting waveforms of both 
the pulmonary arterial blood pressure (Channel 2) and the 
relative blood flow through the artificial ventricle (Chan­
nel 5) are also shown in this recording. 
The shape of the air pressure waveform suggests that 
it is simply a periodic train of rectangular pulses. How­
ever, the actual waveform can be modified by many factors: 
1) the load imposed upon the pneumatic power system by the 
artificial ventricle; 2) the settings of the various air 
bleed-off valves and the regulator-reducer valve; 3) the 
^Statham PE23AC, Statham Instruments, Incorporated, 
Hato Eey, Puerto Rico. 
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diameters and lengths of the tubing used in.the pneumatic 
circuit; 4) the orifice sizes of the solenoid valve and the 
speed with which the valve opens and closes; 5) the pressure 
reserve of the compressed air supply; and 6) the density of 
the gas used. 
ÎÎ0 attempts were made to produce a particular air pres­
sure waveshape. The pneumatic power system could be improved 
by utilizing an air pressure waveform shaping device. Stud­
ies could then be conducted to investigate the effects of 
various air pressure waveforms upon systemic and pulmonary 
arterial blood pressure and blood flow waveforms. An in­
crease in the rise time of the air pressure pulse would 
result not only in lower accelerative forces being impressed 
upon the blood in the ventricle but also in lower peak blood 
pressures in the outflow line. Blood trauma, as well as 
inertial movements of the ventricle itself, may occur if the 
air pressure increases too abruptly. Another desirable 
feature would be the incorporation of a negative pressure 
adaptor to assist the diaphragm of the artificial ventricle 
during the filling phase. Waveshaping devices have been 
developed and utilized (58). Kolff ^  al. (66) produced 
an instrument to study the effects of various air pulse 
waveshapes upon an animal's actual arterial blood pressure. 
They found that an h-shaped air pressure waveform produced 
the most natural arterial blood pressure waveform. 
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The Automatic Control System 
Concurrent with the development of the pneumatic power 
system, a feedback control system was designed to automat­
ically adjust the liquid output of the artificial ventricle. 
Briefly, the control system altered the ventricle's stroke 
volume (and thus its liquid output) in response to changes 
in pressure in the ventricle'.s liquid input line. By this 
means, the control system was sensitive to changing require­
ments of an experimental animal's circulatory system. Input 
line pressure (similar to atrial pressure) was selected as 
the controlling parameter since this variable has been found 
to be a significant factor in normal heart regulation and 
in other artificial ventricle control systems and it is 
easily measured (24, 58, 66, 98, 112, 121). 
Some basic considerations of this pressure servomecha-
nism are worth briefly noting. Being a feedback system it 
is immune to many shortcomings of open loop systems since the 
input knows what the output is doing (but possibly not 
immediately) and makes any necessary corrections. It is 
reasonably immune to alterations in valve friction, tubing 
size, air pressure, and other difficulties which affect the 
forward path (59). However, it has a low tolerance to 
difficulties in the feedback path. Thus the necessity of a 
reliable feedback path is obvious. 
The liquid input line pressure was converted to a 
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voltage to which the control system was actually responsive. 
If the pressure-proportional voltage left a preset reference 
zone, a motor-valve assembly was activated. This assembly 
altered the air pressure available to the artificial ventri­
cle and thus the ventricle's stroke volume. 
Following the fabrication of the control system, two 
artificial ventricles (Model II) and the power and the 
control systems were integrated to produce a semiautomatical-
ly-controlled two-chambered artificial heart which had a 
variable stroke volume and a fixed pulse rate. 
The operation and components of the control system will 
be described with reference to Figure 26. This figure is a 
block diagram depicting a one-ventricle control system in 
relation to the cardiovascular system. Depending on the 
animal procedure being used to test the system, the pressure 
signal was taken from the right atrium (or vena cavae) or 
from the left atrium. In any event, the chosen pressure 
corresponded to that in the liquid input line of the artifi­
cial ventricle. 
The pressure transducer used was a Statham^ PH23-12-300 
differential type with a range of -50 to +50 mm. Hg. This 
is a strain gauge transducer with four active arms in a 
Wheatstone bridge configuration. The frequency response of 
1 Statham Instruments, Incorporated, Sato Rey, Puerto 
Hico. 
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the transducer is essentially flat from zero to 20 cycles 
per second thus making it quite adequate for its purpose 
(122). The transducer was powered from a ten volt power 
supply and was connected to the liquid input line of the 
artificial ventricle by a small liquid-filled catheter. Care 
was taken to assure that the transducer's pressure-sensitive 
diaphragm was at the same level as the desired point of 
pressure measurement in the artificial ventricle. The 
transducer's electrical signal was amplified by a small 
solid-state, fixed-gain operational amplifier.^ The output 
of this amplifier was made available for recording purposes. 
The disadvantage to this means of pressure measurement 
was in the use of a large external transducer and its 
accompanying catheter. The inclusion of a small and accurate 
pressure transducer in the artificial ventricle would be 
advantageous. Any measurement error due to position and/or 
movement would then be reduced to a minimum: A small (l/4 
inch diameter x l/4 inch thick) pressure transducer which 
used resistive paint was tested for use. This unit had 
several advantages other than its small size: 1) large out­
put voltage change per unit change in pressure; 2) very 
^Model 1060; Analog Devices Incorporated, Cambridge, 
Massachusetts. 
%Iodel CS-1-54M, Clark Electronic laboratories. Palm 
Springs, California. 
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simple circuitry needed; and 3) low cost. The transducer 
showed good sensitivity and response time but lacked good 
repeatability and was sensitive to mechanical vibration. 
Higher priced units are commercially available, however, 
which have comparable specifications to the Statham trans­
ducer. 
îîext in the signal path (Figure 26) was the highly 
essential indicating and main controlling mechanism — a 
1 double set-point 0-1 milliampere d-c meter relay. The 
pressure-proportional voltage signal (heavily damped to 
suppress transients) was continuously indicated on this 
meter. The meter relay not only made possible an easy and 
exact initial calibration procedure but also provided a 
visual display of pressure regulation. 
Continuous error correction of liquid input line pres­
sure was not possible since the upper- and lower-limit 
detectors of the meter relay gave the control system an 
adjustable "dead" zone. The use of a reference or "dead" 
zone allowed small and normal pressure variations (those due 
to respiration) to occur without control circuit activation. 
Thus the control system was inoperative when the artificial 
ventricle's liquid output was adequate enough to assure the 
maintenance of the chosen pressure reference zone. 
1Model 502-L, API Instruments Company, Chesterland, 
Ohio. 
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The upper and lower limits of the pressure reference 
zone could be easily and quickly set anywhere within a maxi­
mum pressure range of 40 mm. Hg and the reference zone could 
be as small as 0.24 mm, Hg. formally the meter was cali­
brated so that mid-scale (0.5 milliampere) corresponded to 
zero mm. Hg, zero milliamperes corresponded to "-z" mm. Kg, 
and 1.0 milliampere corresponded to "+x" mm. Hg. 
The upper- and lower-limit switching functions of the 
meter relay determined the direction of current in the con­
trol motor's armature and thus its direction of rotation. 
The control motor was a small separately-excited shunt-wound 
d-c unit.1 Its field was continually excited by a 2? volt 
d-c supply while a separate 0 to 35 volt d-c supply provided 
the armature voltage. The speed of the output shaft of the 
control motor was variable from zero to 30 revolutions per 
minute. Thus the error-correcting response time of the con­
trol system could be varied simply by changing the speed of 
the control motor. The motor was connected to the air bleed-
off OOiJTSOL VALVE of the pneumatic system. This valve was 
responsible for controlling the stroke volume of the artifi­
cial ventricle. 
Figure 27 is a photograph of the control motor power 
supply module which can drive two motors. The relays (two 
^Type 2-9-1; John Oster Manufacturing Company, Genoa, 
Illinois. 
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D?DT types per motor) which control the current direction in 
the armature are at the top of the module. The black knobs 
set the desired motor speed. The other switches allow either 
for automatic operation or for manual operation with control 
over the direction of armature rotation. The meter provides 
an indication of relative motor speed (30 revolutions per 
minute,= maximum speed = 1.0). 
Figure 28 is a photograph of the module which contains 
the meter relays and the necessary electronics for both 
powering the pressure transducers and processing their sig­
nals. The Statham pressure transducer is also shown in the 
photograph. The pressure reference zone is determined by 
the settings of the thick meter pointers. The accompanying 
electronics for the meter relays are located in another 
module (Figure 24). The meter relay module is a completely 
self-contained unit (except for a-c power) as far as pressure 
measurement is concerned and can be used as a two-pressure 
monitor for any surgical procedure. 
The remaining components of the two-ventricle control 
system are shovni in Figures 22 and 23. The module shown in 
these two figures has been described earlier. The latter 
figure shows the air bleed-off valves (labeled OOîîTSOL VALVE) 
at the rear of the chassis. To permit a linear displacement 
of the CONTROL VALVE shaft, this shaft was connected to the 
control motor shaft by a six-inch flexible coupling. The 
various lamps (labeled lUC, DSC, A, B, 0, and D) seen in 
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Figure 22 indicate both, when the control motor is operating 
and what it is attempting to do. The HESET button reverses 
the direction of control motor rotation — an event which 
becomes necessary when the COHTSOL YALVS reaches either 
its fully closed or fully opened position. 
The control system is a regulator type (as opposed to a 
follower type) since its purpose is the regulation of the 
liquid pressure in the artificial ventricle's input line 
within a set range regardless of any fluctuations that occur 
as a result of external disturbances (84). The reference 
input, which is the "signal" established as a standard of 
comparison for the feedback control system, is determined 
by the limit markers on the meter relay. The directly con­
trolled variable is the liquid input line pressure since 
it is directly measured and controlled. The stroke-volume 
of the artificial ventricle is actually an indirectly con­
trolled variable even though it constitutes the output of 
the entire system. The stroke volume could also be called 
the output forcing function. 
This is a closed-loop control system since it contains 
a feedback loop and corrective effort is determined by both 
the desired value and the actual value of the controlled 
variable. Negative feedback is utilized to cause the influ­
ence of a disturbance to the regulator to be minimized so 
that the system maintains, within limits, a constant liquid 
input line pressure. Also the controller is a continuous 
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system as opposed to a sampled-data system. 
Finally the control system is subject to further sub­
division due to the relationship between the output forcing 
function (stroke volume) and the actuating or error signal 
(abnormal liquid input line pressure deviation). The system 
is called a maximum-effort type of controller (84, 85). The 
maximum-effort principle is an intentional use of nonline-
arity. It is a nonlinear system since there is no tendency 
for the relationship between the output and input to be a 
constant. A linear controller grades its output in propor­
tion to the error signal (and possibly also to its deriva­
tives and integrals). The linear design therefore arises 
from an error-oriented viewpoint. The maximum-effort view­
point, however, is energy-oriented and involves using all 
available effort to counteract an error whenever corrective 
action is called for. In other words, when the error signal 
leaves a preset range, the control system switches in a set 
amount of power to drive the controlled variable back toward 
its chosen setting. 
To better illustrate this regulator's degree of fine 
control over a measured variable, several simple control 
systems will be described. With reference to Figure 29, 
part a shows a simple on-off response to a measured parameter, 
such as turning on room lamps when the sun goes behind a 
cloud. There is no regulation of the measured parameter and 
there is no feedback. Part b represents the usual home-
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heating system where feedback is combined with on-off re­
sponse. The furnace goes on if the room temperature falls 
below the desired control point. However the room tempera­
ture may climb much higher than desired since no cooling is 
provided. The system of part _c provides both heating and 
cooling and could represent the temperature control of a 
water bath. Hote that the'rate of heating or cooling is 
reduced as the control point is approached. The control 
problem of part d is the same as that of part _ç except that 
two modifications have been incorporated to improve the speed 
and accuracy of the system's response. Heating and cooling 
now operate at a constant rate when called for. This is the 
maximum-effort response. However, in addition a computer 
measures the time derivative of the controlled parameter, 
takes account of the lag time in the temperature-recording 
device, and shuts off the heating or cooling before the 
control point is reached. Thus oscillation of the system is 
quickly damped. Another way to minimize the "hunting" action 
is the use a "bang-bang" controller in which maximum positive 
effort alternates with maximum negative effort in the same 
cycle (85). 
The transfer function for the maximum-effort regulator 
of the artificial ventricle's control system is shown in 
Figure 30. Note that there is a wide degree of adjustment 
possible in several variables: 1) the chosen optimum fluid 
pressure (P); 2) the width of the pressure reference zone 
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(#); and 3) the degree of effort (li) to be expended (actually 
control motor speed). The point ? does not necessarily have 
to be in the center of the pressure reference zone. For the 
control system built in this study, the magnitude of the 
effort exerted is independent of the direction of the error 
present, i.e., j h_ j = j h^j , The alternate case, jh__[ 
|h^[ , would be necessary if, for example, a positive error 
were to be weighted more than a negative error. 
The pressure reference zone (in Figure 30) could be 
compressed to a single vertical line but then the control 
system would be trying to correct for small and continual 
variations. These corrections are unnecessary since small 
pressure variations (respiratory modulation) are normal and 
do not constitute detrimental errors. Thus the control 
system cannot "fight" with the animal in trying to alter 
these normally occurring variations. The zero-width refer­
ence zone control system is briefly discussed by Merriam 
(83). He also demonstrated that, in general, when only 
response errors are weighted in an error measure (i.e., the 
control effort is not weighted), the optimum controller is 
always of the maximum-effort variety. 
The actual optimization of the artificial ventricle's 
control system is an attractive idea but no such attempt to 
do so was undertaken. The underlying concept of optimization 
is quite simple; generate a signal that will vary the con­
trol settings for the process in such a way that a selected 
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performance index stays at an optimum value despite random 
variations in any factors that affect the process (84). 
There are two disadvantages to the maximum-effort con­
trol system. One is that it has a tendency to hunt around 
the zero signal level. However, this is, in part, a function 
of the width of the reference zone. The other is that in 
systems with time constants it is not easy to predict the 
proper moment to switch off the actuator in order to prevent 
overshoot. The experimental performance of the control 
system will be discussed in a later section. However, it 
should be pointed out now that results of animal trials 
indicated that the pressure-responsive control system often 
exhibited a hunting response. It appeared that the animal's 
response time'' was relatively long. In other words, the 
input (reference zone on meter relay) did not know what the 
output forcing function was doing until a significant amount 
of time later. The hunting response was minimized by using 
a small rate of change in error correction, i.e., a rela­
tively small magnitude of effort h. The problem could also 
possibly be alleviated by incorporating a sampling network 
into the control system. 
Although only one pressure signal was used as a 
^The response time of the animal can be considered to be 
the interval of time between a change in artificial ventricu­
lar stroke volume and the resulting change in liquid input 
line pressure. 
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controlling parameter, there was no guarantee that it pro­
vided the best match with the animal's remaining control 
systems (which include various vascular and respiratory 
reflexes). Much work needs to be done on matching these 
remaining regulatory mechanisms of the experimental animal 
to the inanimate control and power systems associated with 
the artificial ventricles. It may be necessary to have a 
rapid response to and a rapid correction of small errors, 
or, quick error response with slow correction may be a better 
combination. Another possibility would be to have a slow 
(or delayed) response to an error along with either a fast 
or a slow rate of error correction. It is very likely that 
various combinations of responses and corrections may prove 
to be optimal. A comprehensive study not only of other 
selected functional cardiopulmonary variables but also of 
various response-correction combinations should be under­
taken, with the goal of determining which one or combination 
of variables would best reflect the circulatory requirements 
of the body and activate the control mechanism. 
More important, it might be desirable to incorporate 
into the system the capability of response to multiple input 
signals. With several physiologic signals as possible 
feedback parameters, it is apparent that some sort of logic 
system would be desirable in order to make optimum use of the 
available physiologic information. A logic system, given 
the parameters and their limits, could decide which parameter 
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should do the controlling and under what circumstances it 
should dominate. Alternately, combinational control of the 
artificial ventricle might be advantageous. By this means, 
several different functions of the artificial ventricle (rate, 
duty cycle, air pressure rise time, etc.) would be controlled 
by separate feedback parameters. This might allow the regu­
latory system to more closely approximate the natural heart's 
mechanisms for control. 
Consideration should also be given to means which will 
assure equal blood flow from both right and left ventricles 
or which will continuously minimize their time-integrated 
flow differences. The scheme of pressure seasing used in 
this control system does give an indication of flow balance. 
If a flow imbalance develops over a short period of time, 
the liquid input line pressure of the artificial ventricle 
changes. The control system senses this change in pressure 
and acts to correct it. The correction also alters the blood 
flow rate and thus tends to suppress the flow imbalance 
(providing vascular resistance does not change appreciably). 
Simultaneous pressure and flow measurements need to be made 
to completely validate this action. 
It can be appreciated that the use of biochemical pa­
rameters might more accurately reflect the varying metabolic 
needs of the tissues. The use of both arterial and venous 
oxyhemoglobin concentrations as feedback parameters has been 
attempted with the system described in this dissertation 
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(34; 55, 41, 42). Satisfactory control (in a dual ventric-
lar bypass experiment) was attained by using venous oxyhemo­
globin concentration to control the right artificial ventri­
cle and by using left atrial pressure to control the left 
artificial ventricle. The advantage of using this combination 
of control parameters was that one (oxyhemoglobin concentra­
tion) insured that the blood flow met the metabolic require­
ments of the tissues, while the other (atrial pressure) 
tended to assure the proper distribution of circulating blood 
volume. 
Finally such factors as the amplitude, duration, and 
frequency of the electrocardiogram's 2-wave might possibly 
be utilized in the regulation of the artificial ventricle. 
The atrial contribution to the electrocardiogram signal is a 
manifestation of central nervous system moderator activity. 
The surgical attachment of the implantable artificial 
ventricle, as is contemplated in future experiments in this 
research, is such that the atria will remain intact and, 
hopefully, viable. If the electrical signal remains active 
and coordinated with circulatory needs, it would make an 




In Vivo Experiments 
Both 3^ vivo (animal) and vitro (bench) experiments 
were conducted to evaluate the artificial ventricles, the 
pneumatic power system, and the automatic control system. 
These experiments were done in order to properly test the 
entire device's overall quality as a normal heart substitute. 
Once a few preliminary bench tests were performed on an 
inanimate model of the circulatory system, vivo studies 
with the device were conducted. Due to the testing sequence 
adopted, a large number of maneuvers were carried out on 
animals before they were done on the circulatory model. The 
animal experiments not only gave a better insight into the 
operation of the complete device, but also led to several 
observations which were later attempted on the external cir­
culatory model, For these reasons, the animal experiments 
will be described first. 
Evaluation of all components in the artificial ventricle 
system was through the use of the dog as the experimental 
animal. Dogs were used in the acute studies mainly because 
of their availability, cardiovascular anatomy, and ease of 
handling. All animals utilized in this research were han­
dled and cared for in the manner described in "Principles 
in the Care and Use of Experimental Animals in the College 
of Veterinary Medicine, Iowa State University." 
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A team consisting of two or three surgeons, an engineer, 
a medical technologist, and an instrumentation technician 
performed the experimental trials. In these procedures 32 
dogs weighing from 15 to 40 kilograms were used. They were 
anesthetized "by giving sodium pentobarbital intravenously 
to attain surgical anesthesia. Intermittent positive pres­
sure ventilation was maintained by using.a commercial res­
pirator.^ Ventilation rate for the anesthetized animals 
was about 200 milliliters of oxygen per kilogram per minute 
(81) .  
The in vivo testing involved the development and utili­
zation of three types of short-term, open-chest procedures. 
Since the goal of the project was to develop a successful 
system, the protocol for each procedure varied from one ex­
periment to the next because it incorporated changes sug­
gested from the results of earlier trials. The three pro­
cedures used were 1) total cardiopulmonary (heart-lung) 
bypass, 2) right ventricular bypass, and 3) left ventricular 
bypass. (Dual ventricular bypass experiments were performed 
on 33 dogs using this system in conjunction with another 
project (34, 41). In these procedures, both right and left 
natural ventricles were surgically removed and circulation 
was maintained using the Model II ventricles.) Generally a 
^Prothoracic PR-3 respirator. Professional Veterinary 
Supply, Miami, Florida. 
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fixed artificial heart rate of 80 beats per minute was 
employed and 33 l/3 percent of the pumping cycle was systole. 
The majority of the in vivo trials were individual right 
and left ventricular bypasses. In these procedures, the 
natural ventricles were bypassed but left intact and did not 
pump blood (except for flow into the coronary circulation 
from the left ventricle). The lungs oxygenated the blood. 
The Model II artificial ventricles were located extra-
corporeally in all experiments and were connected to the 
animal's vascular system with short lengths of polyvinyl 
chloride tubing. The connections used were from the right 
auricle (or vena cavae) to the right artificial ventricle 
and then to the pulmonary artery. The blood from the left 
auricle was passed through the left artificial ventricle 
and into the aorta (or femoral arteries). Each artificial 
ventricle was used interchangeably in these trials. A 
series of surgical procedures was first required to establish 
these techniques as standard test methods'. 
Uaturally open-chest experiments do not impose normal 
operating conditions on the animal's cardiovascular system 
since the pressures in the thorax are obviously altered. 
To get optimum performance from an anesthetized animal, the 
chest should be closed. This will also reduce the suscepti­
bility to surgical shock. However, open-chest trials nat­
urally precede closed-chest trials and the data obtained can 
be validly related to other types of procedures. 
J 
124 
The pumping system (without feedback control) was used 
effectively in total heart-lung bypass experiments. This 
preparation was utilized in 12 dogs to evaluate the pumping 
ability of both the pneumatic power system and the Model II 
ventricles. Normal flow rates for a dog (at normothermia) 
of approximately 100 to 400 milliliters per kilogram per 
minute were sought (20). 
A right thoracotomy was performed through the fifth 
intercostal space. The azygos vein was ligated. Heparin 
(three milligrams per kilogram of body weight) was given at 
this time in order to prevent blood coagulation during the 
ensuing procedures. The pericardial sac was incised and 
cannulas were inserted into the anterior and posterior vena 
caval veins through incisions in the wall of the right atrium. 
Loops of umbilical tape were placed around the vena cavae 
1.5 centimeters from the tips of the cannulae. The left 
femoral artery was cannulated with a relatively large can­
nula. Catheters were inserted in the right femoral artery 
and right jugular vein for the purpose of measuring central 
arterial and venous pressures respectively. By occluding 
the caval ligatures all systemic venous blood, except that 
returning through the coronary veins, could be shunted 
through the extracorporeal circuit. 
The total heart-lung bypass procedure is schematically 
illustrated in Figure 31. The external blood path consisted 
of a bubble oxygenator, a device for heating or cooling the 
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blood, and the artificial ventricle. Blood-gas interchange 
was accomplished by bubbling either 100 percent oxygen or 
95 percent oxygen and five percent carbon dioxide through 
the bubble oxygenator. In these trials, the artificial 
ventricles performed as well as a commercial finger-type 
blood pump. 
The second procedure used was a right ventricular by­
pass. This procedure was the primary technique used to 
evaluate the complete system. In 14 dogs a left thoracotomy 
was performed through the fourth intercostal space. An in­
take cannula for the artificial ventricle was placed in the 
right atrium. A second cannula was inserted in the pulmonary 
artery through a right ventriculotomy incision. A loose 
ligature was placed around the pulmonary artery. By tight­
ening this loop around the cannula outflow from the right 
ventricle was prevented and all the blood entering the right 
atrium was made to flow through the external circuit. This 
procedure is shown in Figure 32. The artificial ventricle 
was evaluated as a replacement for the natural right ventri­
cle using this open-chest technique. 
The third procedure involved a left ventricular bypass, 
and was used in six dogs. The blood shunting technique was 
similar to that described above, except that the intake can­
nula for the extracorporeal circuit was placed in the left 
atrium and the outflow cannula was placed in the right fem­
oral artery. During bypass a clamp was placed on the aorta 
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doirastream from the origin of the coronary arteries, thus 
blocking aortic blood flow to the periphery. In this proce­
dure the artificial ventricle replaced the function of the. 
natural left ventricle except for furnishing coronary arte­
rial "blood flow. This third procedure is illustrated in 
Figure 33. Bypass techniques in which the individual ventri­
cles were shunted did not require an external blood-gas 
exchanger since the pulmonary circulation was not interrupted. 
In order to evaluate not only the components of the 
artificial ventricle system but also the condition of the 
animal, the following parameters were monitored utilizing 
appropriate transducers and multichannel paper recorders.^ 
1. Electroencephalogram (3SG) 
2. Electrocardiogram (EKG) 
3. Aortic blood pressure — strain gauge transducer 
and fluid-filled cannula 
4. Pulmonary arterial blood pressure — strain gauge 
transducer and fluid-filled cannula 
5. Right atrial blood pressure — strain gauge 
transducer and fluid-filled cannula 
6. left atrial blood pressure — strain guage 
transducer and fluid-filled cannula 
7. Thoracic esophageal temperature — thermistor 
^Grass Model 5 and Model 7 Polygraphs, Grass Instru­
ments Company, Quincy, Massachusetts. 
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8. Blood flow rate through the artificial ventricle — 
electromagnetic flowmeter 
9. Air pressure waveform in the artificial ventricle — 
strain gauge transducer and air-filled cannula 
Note that parameters No. 5 and lo. 6 are the signals asso­
ciated with the automatic control system. 
SKG and SEG potentials were monitored because they are 
sensitive indicators of myocardial and brain function re­
spectively. Deterioration of these signals during the trials 
could be interpreted as evidence of inadequate oxygenation 
of these vital tissues. 
During each surgical procedure blood biochemical and 
hematological studies (pH, pQg, P0O2» hematocrit, total 
hemoglobin, and plasma hemoglobin) were also used to evaluate 
the animal's condition. The blood samples used for gas 
concentration determinations were refrigerated and then 
transported to a local hospital for testing following com­
pletion of the experimental procedure. 
The presurgical bioelectric and blood biochemical and 
hematological control values for each animal were compared 
with those values determined during experimentation. It 
should be mentioned that in trials where maximum survival 
time is to be sought, additional criteria (physical condi­
tion, mental alertness, etc.) might be included in the 
overall evaluation of the animal-machine combination. 
The primary criterion for evaluating the performance 
128 
of the artificial ventricle system in the above trials vas 
the ability of the equipment to maintain the animals in as 
near normal state of homeostasis as possible concommittant 
with adequate atrial (input line) pressure regulation. In 
the right ventricular bypass procedures, experimental ma­
neuvers were conducted to vary vena caval blood pressure. 
Circulating blood volume, one of the determinants of venous 
pressure, was varied by 1) removing blood, 2) infusing five 
percent dextrose solution or ten percent dextran in five 
percent dextrose, and 3) infusing, in single doses or con­
tinuously, hypertensive drugs and ganglionic blocking agents. 
Venous pressures were also momentarily changed by varying 
intrapulmonic pressure during intermittent positive pres­
sure ventilation. Finally perturbations were induced in a 
satisfactorily functioning animal preparation by manually 
altering the fluid output of the artificial ventricle. The 
control system's function, then, was to restore the animal's 
altered venous pressure back to its normal level (determined 
by the limit points on the meter relay) after these changes 
occurred. The response times of the venous pressure regu­
lating system were of particular importance in these trials. 
Figure 34 shows recordings of EKG, pulmonary arterial, 
systemic arterial, and vena caval blood pressures, relative 
mean blood flow rate through the artificial ventricle, and 
ESG taken during a right ventricular bypass test of the 
system. The hash-marked sections of the time channel 
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(center recording) indicate intervals in which the control 
motor was active. The D and I markings indicate attempts 
of the control system to decrease or increase the vena caval 
blood pressure respectively. The slow corrections in vena 
caval blood pressure are easily seen as are similar waveform 
changes in pulmonary and systemic arterial pressures and 
artificial ventricular blood flow. In this control sequence, 
the overcorrecting response of the animal-machine system was 
due to too fast a response time of the automatic control 
system. This overcorrecting (or hunting) response can be 
minimized by matching the control system's response time to 
that of the animal's. Varying the speed of the control motor 
conveniently changes the control system's response time. 
This latter effect is also demonstrated in Figure- 34 where 
the motor speed in the right half of the recording was 
faster than that in the left half. The various blood pres­
sures and the blood flow show continual change as the CONTROL 
VALVE varies its position when the control system is oper­
ating. 
Another example of corrective control sequences with 
different system response times in a right ventricular bypass 
procedure is shoifn in Figure 35. The first and second hash 
marks on the time channel indicate, respectively, an in­
crease and decrease in control motor speed. The third hash 
mark indicates where the automatic feature of the control 
system was turned off. It is easily seen how changes in 
control motor speed affect the period and amplitude of the 
cyclic vena caval blood pressure waveform. Again these 
cyclic variations are evident in some recorded parameters 
other than the vena caval blood pressure. 
The control system's response to alterations in vena 
caval blood pressure can also be studied by perturbations 
to the animal-machine combination such as those shown in 
Figure 36. In these instances the source air pressure was 
manually decreased. This caused an immediate decrease in 
stroke volume of the artificial ventricle which in turn 
allowed the venous pressure to rise. The increase in venous 
pressure triggered the control system and within 70 seconds 
of the onset of the initial change the blood flow and blood 
pressures were back to their previous levels. The right 
section of the figure also shows a similar perturbation 
only with mean levels of some of the parameters being re­
corded. Again the control system equilibrated the venous 
pressure within several cycles. The extreme left end of the 
figure shows expanded recordings of the measured parameters. 
During the right ventricular bypass trials it was pos­
sible to maintain almost normal systemic arterial pressure 
and blood flow with only a slight increase in vena caval 
blood pressure, providing the circulating blood volume was 
adequate and kept fairly constant. îlo changes were observed 
in the waveforms of the SKG and EEG biopotentials during 
bypass. The preservation of normal waveforms (for the 
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anesthetic state) inferred adequate oxygenation of those 
tissues which have high oxygen requirements. 
Negative pressure, developed in the input line during 
the filling phase of the artificial ventricle, often caused 
the collapse of atrial tissue into the right atrial cannula, 
thus severely limiting the blood flow. It is possible that 
this phenomenon is more pronounced in a short-term open-
chest trial than it would be in a closed-chest trial using 
an implanted device. In the latter case, surgical connec­
tions to the natural heart would allow the atrial chamber 
to function more efficiently as a buffer chamber to reduce 
the pressure gradients occurring between the central veins 
and the artificial ventricle's blood chamber. 
In addition to ventricular bypass experiments, it is 
important to conduct both ventricular assist studies and 
total ventricular replacement studies. The circulation 
pattern in the assistive studies puts two artificial ven­
tricles into parallel operation with the natural ventricles. 
By controlling the blood flow through the natural ventri­
cles, the blood flow through the artificial ventricles can 
be varied from zero to full "cardiac" output. 
In order to conduct the total replacement studies a 
method must be developed to attach the proper ports of each 
artificial ventricle to the aorta, pulmonary artery, and 
right and left atria. Also a surgical procedure to perform 
a satisfactory bilateral ventriculectomy is necessary. This 
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procedure will assure that an adequate portion of the coro­
nary blood supply will be retained to maintain atrial myo­
cardial tissue in a viable state. By not removing the atria, 
important reflexes from their walls will be preserved and 
may possibly be utilized as a means of feedback control. 
Finally a technique must be established for a smooth, flaw-
proof conversion from total cardiopulmonary bypass to total 
implanted artificial ventricular function. The best combi­
nation of anesthetic procedures must be determined to mini­
mize depression of the central nervous system and the re­
spiratory and vascular regulatory mechanisms. There is a 
likelihood that a more efficient external control system is 
required for an animal preparation lacking the control 
mechanisms of a natural heart. 
Providing that all of the above listed phases were 
carried out satisfactorily, an artificial ventricle could be 
implanted using aseptic technique and then evaluated in 
closed-chest, conscious animals. Cardiovascular studies 
might include those enumerated above and, when possible, 
postoperative clinical, clinicopathological, and gross and 
microscopic tissue evaluations to determine the adequacy of 
the artificial ventricles. 
In Vitro Experiments 
This section is concerned with the performance of a 
single Model II artificial ventricle and its control system 
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in conjunction with a specialized test circulation. The 
response of the ventricle's liquid input line pressure to 
various disturbances was sought under differing conditions 
of control motor operation. Water was used for the circu­
lated fluid in all cases. 
A diagram of the experimental layout is shown in Figure 
37. The output of the artificial ventricle was returned to 
the constant level reservoir. This reservoir was also sup­
plied with tap water to assure a constant flow from the 
reservoir regardless of the artificial ventricle's flow rate. 
The constant level reservoir drained into the ventricle's 
filling reservoir. The liquid input line pressure (control 
signal) was proportional to the level (h^) of the water in 
the filling reservoir above, the pressure•transducer.' 
I'ote that a closed circulation was not used. Since the 
test circulation possessed no distensibility, there were no 
temporary storage areas for the liquid. Thus to transfer 
volumes of liquid, both liquid inflow and outflow tracts were 
added to the test circulation. Note that since only one 
ventricle was employed in the test circulation, interaction 
between two pumps was absent. Naturally this interaction is 
present in the normal circulatory system. 
Even though the test circulation was not closed, the 
control system did possess a closed loop. In Figure 37 it 
can be seen that the loop was a combination of electrical, 
mechanical, pneumatic, and hydraulic elements. The sensing 
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and control path was composed of the following sections in 
sequence: liquid input line pressure to the artificial ven­
tricle; pressure transducer; amplifier; meter relay; control 
motor; air bleed-off control valve; and the artificial ven­
tricle . 
Consider the test circulation to be in equilibrium. 
Then the flow rate through the artificial ventricle is con­
stant and is such that there is no change in the level h^. 
In other words, the artificial ventricle is pumping all that 
comes to it by way of the constant level reservoir. Into 
this steady-state condition suppose a perturbation is intro­
duced by a change in any one of the following variables: 1) 
pulsed air pressure (i.e., stroke volume); 2) flow rate into 
the filling reservoir; 3) the level h^; or 4) limit markers 
on the meter relay. Any one of these changes will lead to 
the establishment of a liquid input line pressure which is 
outside the chosen pressure reference zone. In other words, 
an error signal will be generated. The control motor will 
then be activated and the artificial ventricle's stroke 
volume will be altered in an attempt to restore the original 
operating point. By varying the speed of the control motor, 
with all other variables being held constant, various re­
sponses can be obtained and recorded as the control system 
reacts to the disturbances in the test circulation. 
All of the above perturbations were induced into the 
equilibrated test circulation. In all trials the air bleed-
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off control valve was initially set at the same position and 
the artificial ventricle's rate was 70 beats per minute while 
its duty cycle was 35 percent. All of the ^  vitro trials 
exhibited the same behavior — the liquid input line pressure 
showed an oscillatory response with a linearly increasing 
amplitude. This behavior continued until the air bleed-off 
control valve reached its fully closed position at which time 
the control system was automatically deactivated and the 
trial terminated. Thus the test circulation-control system 
composite was unstable. 
Tifo recordings will be presented which illustrate the 
system's response to two perturbations under two different 
control conditions. The recordings were made on a Grass 
Model 7 Polygraph at a paper speed of 0.50 millimeters per 
second. The slow paper speed was the reason that only the 
envelope of the air pressure waveform is seen. 
Figure 33 shows recordings of control motor effort, air 
pressure at the base of the artificial ventricle, and liquid 
input line pressure. The two pressures were measured in 
millimeters of mercury (mm. Hg). In this trial the meter 
relay was calibrated for a full scale pressure reading of 8.0 
mm. Hg (thus the meter's sensitivity was 0.16 mm. Kg per 
division), the width of the pressure reference zone was 5.0 
divisions (0.80 mm. .Hg), and the relative motor speed was 
0.20. The meter relay limit markers were set so that the 
meter indication was in the center of the reference zone in 
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the steady-state condition. 
At the event mark (fourth tracing) both limit markers 
on the meter relay were increased by three divisions (0.48 
mm. Hg). This action simulated a step decrease in the liquid 
input line pressure. The control system interpreted this 
event as a condition in which the artificial ventricle's 
stroke volume was excessive. A reduction in stroke volume 
was initiated to bring about an increased liquid input line 
pressure. These events are obvious in all three tracings 
of Figure 38. The INC and DEO designations indicate, re­
spectively, efforts by the control system to increase and 
decrease the liquid input line pressure. The unstable grow­
ing response (which terminated at the asterisk) is easily 
seen. ÎTote also that the duration of each individual control 
effort period was longer than its predecessor. 
In an attempt to eliminate the unstable response, 
intermittent operation of the control motor was next used. 
A timing circuit allowed the control motor to function for 
only a percentage of the time whenever an error signal was 
present (47). The "sampling" rate was adjustable from two 
to 60 samples per minute and the duration of control motor 
action was adjustable from 0.5 to 25 seconds. Different 
settings of these two adjustments,then,, could produce control 
motor duty cycles of 1.67 to 100 percent. The cycling of 
the timing circuit was independent of the error signal. 
Figure 39 shows the result of a trial in which the 
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sensitivity of the meter relay was 0.16 mm. .Hg per division, 
the pressure reference zone width was three divisions (0.48 
mm. Hg), and the relative motor speed was 0.40. The duty 
cycle of the control motor was 50 percent (five seconds "on" 
and five seconds "off"). At the event mark a slight decrease 
in liquid flow rate into the filling reservoir was initiated. 
The control system interpreted this event as a condition in 
which the artificial ventricle's stroke volume was excessive. 
A reduction in stroke volume was initiated to bring about 
an increase in the liquid input line pressure. Again, these 
events are obvious in all three traces of the recording as is 
the resulting unstable growing response. 
There are several possible explanations for the unstable 
responses obtained in these trials: 
1. The stroke volume of the artificial ventricle was 
not a function of its input filling pressure. Thus, 
with a deactivated control system, the ventricle's 
liquid flow rate would be s.table regardless of the 
level hy (in Figure 37). 
2. Only one parameter was utilized as a control signal 
(liquid input pressure) even though two parameters 
were varying (liquid input pressure and pulsed air 
pressure). Thus a return to a stable condition 
necessitated that both parameters attain their pre-
perturbation values simultaneously. It was not 
sufficient that only the control signal parameter 
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returned to its Initial value. 
3. The use of too large a diameter (l4 centimeters) 
filling reservoir caused a considerable degradation 
in the control system's performance. A pressure 
reference zone width of five divisions (0.80 mm. Hg) 
meant that the level h^ had to change by 1.09 centi­
meters for the meter indication to travel the width 
of the zone. Thus, with a small ventricular flow 
imbalance, a significant amount of time was needed to 
change this level and the control system was not 
immediately aware of either what or when corrective 
maneuvers were taking place. 
The above results were presented only to show the control 
system's performance when used with a specific test circula­
tion. Many refinements could have been added to the system 
such as rate feedback and synchronization of the intermittent 
control motor operation with the initiation of an error. But 
since the test circulation itself was not a true model of the 
normal circulatory system, effort spent on refinements would 
be of limited value. 
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SUmAEY km CONCLUSIONS 
The research described in this dissertation is ultimately 
directed toward a problem which occurs in heart attack cases, 
that of adequate treatment for the irreversibly damaged heart. 
Such a heart is one where partial recovery and healing cannot 
occur even after temporary assistance by either a heart-lung 
machine or an artificial intrathoracic bypass pump. 
The many technical problems relating to the development 
of a satisfactory heart substitute have been discussed. 
These include the use of proper materials which will satisfy 
both the physiologic and physical requirements imposed by 
years of uninterrupted service. For portable automatic con­
trol, transducers for permanent implantation together with 
miniaturized circuitry must be designed and optimally uti­
lized. A driving mechanism must be provided to continuously 
energize the artificial heart. The intrathoracic pump must 
minimize heat production to levels which are safe and toler­
able by the body. Finally, an energy source which is port­
able, reliable, and powerful must be provided. Significant 
advances in all the above-mentioned areas will open new 
possibilities of sustaining useful and productive life in 
certain selected clinical cases of otherwise fatal heart 
disease. 
The design and performance of the artificial ventricles 
and the power and control systems developed in this research 
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have "been described. The limitations of the system were 
mentioned along with recommendations for improvement. Both 
in vivo and ^  vitro experiments were conducted with the 
in vivo trials being the ultimate tests for adequate per­
formance. The main emphasis in the vivo experiments was 
on the performance of the entire system in short-term animal 
trials. long-term animal survival was not sought. The in 
vitro experiments were conducted to determine some capabil­
ities of the overall system. 
The results of automatic control of an artificial ven­
tricle using a single physiologic parameter were, for the 
most part, encouraging. However, studies should be conducted 
to compare the relative efficacy of several physiologic 
events utilized to control single and dual artificial ven­
tricles both in assistive and in total ventricular replace­
ment modes. 
It is hoped that this research can contribute both to 
the investigations of control problem aspects of implantable 
artificial hearts and to the treatment of the irreversibly 
damaged human heart. Although many obstacles impede the 
achievement of total success in this endeavor, the difficul­
ties seem not to be of any greater magnitude than those found 
as a result of natural heart transplantation. 
Finally, to philosophize a little and borrow some words 
of Willem J. Kolff (64); 
"life might still be acceptable if a vigorous artificial 
1 Al 
heart could be supplied, ever, if two small tubes would have 
to connect the patient with some kind of pressure system. 
It is not a solution that any normal man would look forward 
to, but for the patient in desperate heart failure, what 
would be the alternative?" 
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Pigure 1. Pictorial diagram of the iiuman circula­
tory system (Guyton, 52, p. 249) 
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Figure 2. Block diagram of the human and canine 
cardiovascular system. Number in ( ) is 
the mean blood pressure in millimeters of 
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Figure 3. Ventricular function curves 
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Figure 4. Cardiac output curves (Guyton, 
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Figure 5. The normal venous return curve 
(Guyton, 51, p. ^ 57) 
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Figure 6. The effect of systemic resist­
ance on the venous return curve 
(Guyton, 51, p. 458) 
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figure 7. Superposition of the normal cardiac output 
curve and the normal venous return curve 
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Figure 8. The effect of sympathetic stimulation on 
venous return, cardiac output, and right 
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Figure 9. The reference point for pressure measurement 











Figure 10. Diagram of a fluid-actuated artificial ven­

























Figure 11. Causes of death in artificial heart experi­
ments (Atsumi, £t a^., 9, p. 297) 
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Figure 12. Means of power transmission through the chest 
wall (Seidel, et , 110, p. 384) 
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CLOSE DUPLICATION OF HEART FUNCTIONS 
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Figure 13. Advantages of a fluid amplifier-controlled 
artificial heart (Barila, ^  , 10, p. 32) 
Figure 14. Silicone rubber flap valves for the Model II 
artificial ventricle; C = flap part, D = 
seating part 
Figure 15. Cross-section view of the Kodel II 
artificial ventricle (Letters are 
explained in the text.) 
167 
Figure 16. The three artificial ventricles 
Figure 17. The disassembled Model II arti­
ficial ventricle (Letters are 
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Figure 18. Liquid output of the Model II ventricle as a 
function of both output pressure head and 
pulsed air pressure. • The number in ( ) is 
the resting level of the pulsed air pressure 
in pounds per square inch. The input filling 
pressure was five mm. Hg. 
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rigure 19. Liquid output of the Kodel II ventricle as a 
function of both input filling pressure and 
pulsed air pressure. The number in ( ) is 
the resting level of the pulsed air pressure 
in pounds per square inch. The output pres­
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Figure 20, Appearance of plasma hemoglobin as 
a function of time for a Model II 
artificial ventricle 

























Figure 21 . Block diagram of a one-ventricle pnç jiatio pov7er system 
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Pressure control module — front view 
Figure 23. Pressure control module — rear view 
I 
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figure 24. Heart rate and duty cycle module 
Figure 25. Plow and pressure recordings 
Figure 26. Block diagram of a one-ventricle control 
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Figure 27. Control motor power supply module 
Figure 28. Meter relay module and Statham 
PH23-1D-300 pressure transducer 
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igure 29. Responses of four control systems 
(Bellman, 11, p. 190) 
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Figure 30. Transfer function for the maximum-effort regulator 
Figure 31. Schematic diagram of the total 
cardiopulmonary bypass procedure 
Figure 32. Schematic diagram of the right 
ventricular bypass procedure 
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Figure 33. Schematic diagram of the left 
ventricular bypass procedure 
Figure 34. Recordings taken during an _in vivo 
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Figure 35. Recordings taken during an vivo 
automatic control sequence — effect 
of control motor speed on machine 
response 
Figure 36. Recordings taken during an ^  vivo 
automatic control sequence — response 













Figure 37. Diagram of the test circulation and its 
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Figure 58. Recordings taken during an vitro 
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Figure 39. Recordings taken during an iji vitro 
automatic control sequence — unstable 
oscillating response with intermittent 
control motor operation 
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TABLE 
Table 1. Specifications of the three artificial ventricles 
Size in 
centi­
meters, Weight Air chamber Diastolic Stoke 
length X in volume in volume in volume in 
Model diameter grams milliliters milliliters milliliters 
I 30.1 X 9.5 406 44 - 196 70 0 - 25 
II 7.0 X 6.5 234 15 - 40 34 - 90 0 1 o
 
III 15.0 X 11 .4 666 70 - 200 155 0 - 100 
